Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
HIV Med
    September 2021
  1. LEE MJ, Snell LB, Douthwaite ST, Fidler S, et al
    Clinical outcomes of patients with and without HIV hospitalized with COVID-19 in England during the early stages of the pandemic: a matched retrospective multi-centre analysis (RECEDE-C19 study).
    HIV Med. 2021 Sep 23. doi: 10.1111/hiv.13174.
    >> Share

  2. MAZZITELLI M, Branca Isabel P, Muramatsu T, Chirwa M, et al
    FRAX assessment in people ageing with HIV.
    HIV Med. 2021 Sep 19. doi: 10.1111/hiv.13170.
    >> Share

  3. BROWN AE, Croxford SE, Nash S, Khawam J, et al
    COVID-19 mortality among people with diagnosed HIV compared to those without during the first wave of the COVID-19 pandemic in England.
    HIV Med. 2021 Sep 15. doi: 10.1111/hiv.13167.
    >> Share

  4. BURKE RM, Rickman HM, Singh V, Kalua T, et al
    Same-day antiretroviral therapy initiation for people living with HIV who have tuberculosis symptoms: a systematic review.
    HIV Med. 2021 Sep 15. doi: 10.1111/hiv.13169.
    >> Share

  5. VENKATESH KK, Edmonds A, Westreich D, Dionne-Odom J, et al
    Associations between HIV, antiretroviral therapy and preterm birth in the US Women's Interagency HIV Study, 1995-2018: a prospective cohort.
    HIV Med. 2021 Sep 12. doi: 10.1111/hiv.13171.
    >> Share

  6. BONOU M, Kapelios CJ, Protogerou AD, Mavrogeni S, et al
    Cardiac adiposity as a modulator of cardiovascular disease in HIV.
    HIV Med. 2021 Sep 12. doi: 10.1111/hiv.13166.
    >> Share

  7. CHOI JY, Lui GCY, Liao CT, Yang CJ, et al
    Managing cardiovascular risk in people living with HIV in Asia - where are we now?
    HIV Med. 2021 Sep 7. doi: 10.1111/hiv.13164.
    >> Share

  8. LAHER AE, Paruk F, Venter WDF, Ayeni OA, et al
    Development and internal validation of the HIV In-hospital Mortality Prediction (HIV-IMP) risk score.
    HIV Med. 2021 Sep 5. doi: 10.1111/hiv.13159.
    >> Share

  9. HACHFELD A, Atkinson A, Calmy A, de Tejada BM, et al
    Decrease of condom use in heterosexual couples and its impact on pregnancy rates: the Swiss HIV Cohort Study (SHCS).
    HIV Med. 2021 Sep 2. doi: 10.1111/hiv.13152.
    >> Share

  10. TARAMASSO L, Bonfanti P, Ricci E, Maggi P, et al
    Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade.
    HIV Med. 2021 Sep 2. doi: 10.1111/hiv.13165.
    >> Share

  11. LEAKE DATE HA, Alford K, Hounsome N, Moore D, et al
    Structured medicines reviews in HIV outpatients: a feasibility study (The MOR Study).
    HIV Med. 2021 Sep 1. doi: 10.1111/hiv.13158.
    >> Share

  12. KRAEF C, Bentzon A, Skrahina A, Mocroft A, et al
    Improving healthcare for patients with HIV, tuberculosis and hepatitis C in eastern Europe: a review of current challenges and important next steps.
    HIV Med. 2021 Sep 1. doi: 10.1111/hiv.13163.
    >> Share

    August 2021
  13. SPARKS E, Zorzela L, Necyk C, Hughes C, et al
    Study of natural product adverse events in adult HIV-infected patients in Canada.
    HIV Med. 2021 Aug 25. doi: 10.1111/hiv.13155.
    >> Share

  14. WHITLOCK GG, Protopapas K, Bernardino JI, Imaz A, et al
    Chems4EU: chemsex use and its impacts across four European countries in HIV-positive men who have sex with men attending HIV services.
    HIV Med. 2021 Aug 25. doi: 10.1111/hiv.13160.
    >> Share

  15. SANDERS EJ, Agutu C, van der Elst E, Hassan A, et al
    Effect of an opt-out point-of-care HIV-1 nucleic acid testing intervention to detect acute and prevalent HIV infection in symptomatic adult outpatients and reduce HIV transmission in Kenya: a randomized controlled trial.
    HIV Med. 2021 Aug 25. doi: 10.1111/hiv.13157.
    >> Share

  16. ANIKPO I, Agovi AM, Cvitanovich MJ, Lonergan F, et al
    The data-collection on adverse effects of anti-HIV drugs (D:A:D) model for predicting cardiovascular events: External validation in a diverse cohort of people living with HIV.
    HIV Med. 2021 Aug 19. doi: 10.1111/hiv.13147.
    >> Share

  17. CHALOUNI M, Pol S, Sogni P, Fontaine H, et al
    Direct, indirect and total effect of HIV coinfection on the risk of non-liver-related cancer in hepatitis C virus-infected patients treated by direct-acting antivirals: a mediation analysis.
    HIV Med. 2021 Aug 17. doi: 10.1111/hiv.13153.
    >> Share

  18. PINCUS KJ, Blackman AL, Suen SY, Devabhakthuni S, et al
    Statin gap in patients living with HIV: assessing dose appropriateness.
    HIV Med. 2021 Aug 8. doi: 10.1111/hiv.13150.
    >> Share

  19. FRANGE P, Blanche S, Veber F, Avettand-Fenoel V, et al
    Dolutegravir in the long term in children and adolescents: frequent virological failure but rare acquired genotypic resistance.
    HIV Med. 2021 Aug 8. doi: 10.1111/hiv.13154.
    >> Share


  20. Abstracts of the 5th Joint Conference of the British HIV Association (BHIVA) with the British Association for Sexual Health and HIV (BASHH), Virtual, 19-21 April 2021.
    HIV Med. 2021;22 Suppl 2:3-126.
    >> Share

    July 2021
  21. ROBERTS O, Kinvig H, Owen A, Lamorde M, et al
    In vitro assessment of the potential for dolutegravir to affect hepatic clearance of levonorgestrel.
    HIV Med. 2021 Jul 30. doi: 10.1111/hiv.13136.
    >> Share

  22. LAWAL IO, Orunmuyi AT, Popoola GO, Mokoala KMG, et al
    Immune reconstitution inflammatory syndrome-associated Graves disease in HIV-infected patients: clinical characteristics and response to radioactive iodine therapy.
    HIV Med. 2021 Jul 30. doi: 10.1111/hiv.13148.
    >> Share

  23. DIEZ C, Del Romero-Raposo J, Mican R, Lopez JC, et al
    COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study.
    HIV Med. 2021 Jul 29. doi: 10.1111/hiv.13145.
    >> Share

  24. GIROMETTI N, Delpech V, McCormack S, Khawam J, et al
    The success of HIV combination prevention: The Dean Street model.
    HIV Med. 2021 Jul 29. doi: 10.1111/hiv.13149.
    >> Share

  25. FABBIANI M, Rossetti B, Ciccullo A, Oreni L, et al
    Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort.
    HIV Med. 2021 Jul 27. doi: 10.1111/hiv.13146.
    >> Share

  26. OKHAI H, Sabin CA, Haag K, Sherr L, et al
    Menopausal status, age and management among women living with HIV in the UK.
    HIV Med. 2021 Jul 26. doi: 10.1111/hiv.13138.
    >> Share

  27. SQUILLACE N, Bernasconi DP, Lapadula G, Soria A, et al
    HPV 16 and 18 contribute to development of anal dysplasia in HIV infection irrespective of gender and sexual orientation.
    HIV Med. 2021 Jul 22. doi: 10.1111/hiv.13143.
    >> Share

  28. BOEKE CE, Khan S, Walsh FJ, Lejeune C, et al
    Longitudinal analysis of client appointment adherence under Universal Test and Treat strategy: A stepped-wedge trial.
    HIV Med. 2021 Jul 22. doi: 10.1111/hiv.13144.
    >> Share

  29. SHARMA I
    Interrogating the impact of combination antiretroviral therapies on HIV-associated neurocognitive disorders.
    HIV Med. 2021 Jul 21. doi: 10.1111/hiv.13142.
    >> Share

  30. TORRES B, Guardo AC, Squarcia M, Diaz A, et al
    Impact of switching to raltegravir and/or adding losartan in lymphoid tissue fibrosis and inflammation in people living with HIV. A randomized clinical trial.
    HIV Med. 2021 Jul 20. doi: 10.1111/hiv.13114.
    >> Share

  31. KIM JH, Noh J, Kim W, Seong H, et al
    Trends of age-related non-communicable diseases in people living with HIV and comparison with uninfected controls: A nationwide population-based study in South Korea.
    HIV Med. 2021 Jul 14. doi: 10.1111/hiv.13139.
    >> Share

  32. LEI JJH, Pereira B, Moyle G, Boffito M, et al
    The benefits of tenofovir discontinuation with or without bisphosphonate therapy in osteoporotic people living with HIV.
    HIV Med. 2021 Jul 13. doi: 10.1111/hiv.13137.
    >> Share

  33. WOLDESENBET SA, Kufa-Chakezha T, Lombard C, Manda S, et al
    Coverage of maternal viral load monitoring during pregnancy in South Africa: Results from the 2019 national Antenatal HIV Sentinel Survey.
    HIV Med. 2021 Jul 1. doi: 10.1111/hiv.13126.
    >> Share

  34. CHALOUNI M, Wittkop L, Bani-Sadr F, Lacombe K, et al
    Risk of severe clinical events after sustained virological response following direct-acting antiviral therapy in HIV and hepatitis C virus coinfected participants.
    HIV Med. 2021 Jul 1. doi: 10.1111/hiv.13127.
    >> Share

  35. CRAWFORD D, Allan B, Cogle A, Brown G, et al
    Client-led care in HIV: perspectives from community and practice.
    HIV Med. 2021;22 Suppl 1:3-14.
    >> Share

    June 2021
  36. LE XQ, Liu DP, Chen J, Gong ZY, et al
    Urinary biomarkers of early renal injury in antiretroviral-naive HIV-positive persons in Shanghai, China: comparison with the general population.
    HIV Med. 2021 Jun 10. doi: 10.1111/hiv.13123.
    >> Share

  37. MURRAY MM, Lin J, Buros Stein A, Wilcox ML, et al
    Relationship of polypharmacy to HIV RNA suppression in people aged >/= 50 years living with HIV.
    HIV Med. 2021 Jun 2. doi: 10.1111/hiv.13122.
    >> Share

  38. ZHABOKRITSKY A, Szadkowski L, Burchell AN, Cooper C, et al
    Immunological and virological response to initial antiretroviral therapy among older people living with HIV in the Canadian Observational Cohort (CANOC).
    HIV Med. 2021 Jun 1. doi: 10.1111/hiv.13125.
    >> Share

    May 2021
  39. KIM J, Nam HJ, Kang SJ, Jung SI, et al
    Integrase strand transfer inhibitor treatment does not increase the incidence of immune reconstitution inflammatory syndrome in HIV-infected Koreans.
    HIV Med. 2021 May 28. doi: 10.1111/hiv.13117.
    >> Share

  40. SCHULZ CA, Mavarani L, Reinsch N, Albayrak-Rena S, et al
    Prediction of future cardiovascular events by Framingham, SCORE and asCVD risk scores is less accurate in HIV-positive individuals from the HIV-HEART Study compared with the general population.
    HIV Med. 2021 May 24. doi: 10.1111/hiv.13124.
    >> Share

  41. MMASA KN, Powis K, Sun S, Makhema J, et al
    Gestational diabetes in women living with HIV in Botswana: lower rates with dolutegravir- than with efavirenz-based antiretroviral therapy.
    HIV Med. 2021 May 18. doi: 10.1111/hiv.13120.
    >> Share

  42. REGO DE FIGUEIREDO I, Branco Ferrao J, Dias S, Vieira Alves R, et al
    Tuberculosis infection in HIV vs. non-HIV patients.
    HIV Med. 2021 May 17. doi: 10.1111/hiv.13119.
    >> Share

  43. ALBASANZ-PUIG A, Suanzes P, Esperalba J, Fernandez C, et al
    Low frequency of cytomegalovirus (CMV) disease despite high prevalence of CMV viraemia in patients with advanced HIV infection: a clinical and immunological 48-week follow-up study.
    HIV Med. 2021 May 17. doi: 10.1111/hiv.13115.
    >> Share

  44. VORA J, Velhal S, Sinha S, Patel V, et al
    Bioactive phytocompound mulberroside C and endophytes of Morus alba as potential inhibitors of HIV-1 replication: a mechanistic evaluation.
    HIV Med. 2021 May 14. doi: 10.1111/hiv.13116.
    >> Share

  45. GILL MJ, Powell M, Vu Q, Krentz HB, et al
    Economic impact on direct healthcare costs of missing opportunities for diagnosing HIV within healthcare settings.
    HIV Med. 2021 May 12. doi: 10.1111/hiv.13121.
    >> Share

  46. FAN X, Fang J, Wu X, Poulsen K, et al
    Effect of HIV infection on pre- and post-liver transplant mortality in patients with organ failure.
    HIV Med. 2021 May 8. doi: 10.1111/hiv.13113.
    >> Share

  47. BURNS JE, Stohr W, Kinloch-De Loes S, Fox J, et al
    Tolerability of four-drug antiretroviral combination therapy in primary HIV-1 infection.
    HIV Med. 2021 May 8. doi: 10.1111/hiv.13118.
    >> Share

  48. PHALANE E, Fourie C, Schutte AE, Kruger IM, et al
    Arterial structure and function in Africans with HIV for > 5 years: longitudinal relationship with endothelial activation and cardiovascular risk markers.
    HIV Med. 2021 May 5. doi: 10.1111/hiv.13111.
    >> Share

  49. HOWARTH AR, Apea V, Michie S, Morris S, et al
    The association between use of chemsex drugs and HIV clinic attendance among gay and bisexual men living with HIV in London.
    HIV Med. 2021 May 5. doi: 10.1111/hiv.13103.
    >> Share

  50. ASAD H, Collins IJ, Goodall RL, Crichton S, et al
    Mortality and AIDS-defining events among young people following transition from paediatric to adult HIV care in the UK.
    HIV Med. 2021 May 3. doi: 10.1111/hiv.13096.
    >> Share

    April 2021
  51. RICHARDSON D, Nichols K, Pickering A, Devlin J, et al
    Transitioning from HIV post-exposure prophylaxis to pre-exposure prophylaxis in men who have sex with men.
    HIV Med. 2021 Apr 30. doi: 10.1111/hiv.13112.
    >> Share

  52. JANSEN N, Daniels C, Sunil T, Xu X, et al
    Factors associated with erectile dysfunction diagnosis in men with HIV infection: a case-control study.
    HIV Med. 2021 Apr 25. doi: 10.1111/hiv.13107.
    >> Share

  53. KOVARI H, Surial B, Tarr PE, Cavassini M, et al
    Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort Study.
    HIV Med. 2021 Apr 20. doi: 10.1111/hiv.13106.
    >> Share

  54. PATEL PG, Keen P, McManus H, Duck T, et al
    Increased targeted HIV testing and reduced undiagnosed HIV infections among gay and bisexual men.
    HIV Med. 2021 Apr 19. doi: 10.1111/hiv.13102.
    >> Share

  55. EZEAMAMA AE, Zalwango SK, Sikorskii A, Tuke R, et al
    In utero and peripartum antiretroviral exposure as predictor of cognition in 6- to 10-year-old HIV-exposed Ugandan children - a prospective cohort study.
    HIV Med. 2021 Apr 16. doi: 10.1111/hiv.13094.
    >> Share

  56. SAUMOY M, Di Yacovo S, Perez S, Sanchez-Quesada JL, et al
    Carotid atherosclerosis in virologically suppressed HIV patients: comparison with a healthy sample and prediction by cardiovascular risk equations.
    HIV Med. 2021 Apr 5. doi: 10.1111/hiv.13093.
    >> Share

    March 2021
  57. LAHER AE, Paruk F, Venter W, Ayeni OA, et al
    Predictors of in-hospital mortality among HIV-positive patients presenting with an acute illness to the emergency department.
    HIV Med. 2021 Mar 31. doi: 10.1111/hiv.13097.
    >> Share

  58. FOKAM J, Takou D, Njume D, Pabo W, et al
    Alarming rates of virological failure and HIV-1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY-study in Cameroon.
    HIV Med. 2021 Mar 31. doi: 10.1111/hiv.13095.
    >> Share

  59. NKUIZE M, Vanderpas J, Buset M, Delforge M, et al
    Failure to eradicate Helicobacter pylori infection is more frequent among HIV-positive patients.
    HIV Med. 2021 Mar 25. doi: 10.1111/hiv.13083.
    >> Share

  60. MASSAH G, Zhang W, Birungi J, Nanfuka M, et al
    Gender disparities operate in opposite directions for hospitalizations and mortality among individuals receiving long-term ART in rural Uganda.
    HIV Med. 2021 Mar 17. doi: 10.1111/hiv.13080.
    >> Share

  61. CHAN P, Colby DJ, Kroon E, Sacdalan C, et al
    Clinical and laboratory impact of concomitant syphilis infection during acute HIV.
    HIV Med. 2021 Mar 17. doi: 10.1111/hiv.13079.
    >> Share

  62. KANDA N, Okamoto K, Okumura H, Mieno M, et al
    Outcomes associated with treatment change from tenofovir disoproxil fumarate to tenofovir alafenamide in HIV-1-infected patients: a real-world study in Japan.
    HIV Med. 2021 Mar 15. doi: 10.1111/hiv.13061.
    >> Share

  63. D'SOUZA G, Benning L, Stosor V, Witt MD, et al
    The shifting picture of HIV treatment, comorbidity and substance use among US MSM living with HIV.
    HIV Med. 2021 Mar 10. doi: 10.1111/hiv.13082.
    >> Share

  64. ASCHER SB, Scherzer R, Estrella MM, Muiru AN, et al
    Kidney tubule health scores and their associations with incident CKD in women living with HIV.
    HIV Med. 2021 Mar 9. doi: 10.1111/hiv.13081.
    >> Share

    February 2021
  65. JESPERSEN NA, Axelsen F, Dollerup J, Norgaard M, et al
    The burden of non-communicable diseases and mortality in people living with HIV (PLHIV) in the pre-, early- and late-HAART era.
    HIV Med. 2021 Feb 28. doi: 10.1111/hiv.13077.
    >> Share

  66. PUNEKAR YS, Parks D, Joshi M, Kaur S, et al
    Effectiveness and safety of dolutegravir two-drug regimens in virologically suppressed people living with HIV: a systematic literature review and meta-analysis of real-world evidence.
    HIV Med. 2021 Feb 2. doi: 10.1111/hiv.13050.
    >> Share

  67. YANAVICH C, Pacheco AG, Cardoso SW, Nunes EP, et al
    Diagnostic value of serological biomarkers for detection of non-alcoholic fatty liver disease (NAFLD) and/or advanced liver fibrosis in people living with HIV.
    HIV Med. 2021 Feb 2. doi: 10.1111/hiv.13060.
    >> Share

  68. CROXFORD S, Burns F, Copas A, Yin Z, et al
    Trends and predictors of linkage to HIV outpatient care following diagnosis in the era of expanded testing in England, Wales and Northern Ireland: Results of a national cohort study.
    HIV Med. 2021 Feb 2. doi: 10.1111/hiv.13078.
    >> Share

    January 2021
  69. BOOTON RD, Ong JJ, Lee A, Liu A, et al
    Modelling the impact of an HIV testing intervention on HIV transmission among men who have sex with men in China.
    HIV Med. 2021 Jan 28. doi: 10.1111/hiv.13063.
    >> Share

  70. ARMENIA D, Bouba Y, Gagliardini R, Fabeni L, et al
    Virological response and resistance profile in highly treatment-experienced HIV-1-infected patients switching to dolutegravir plus boosted darunavir in clinical practice.
    HIV Med. 2021 Jan 21. doi: 10.1111/hiv.13062.
    >> Share

  71. NOCELLA C, Mezzaroma I, Cammisotto V, Castellani V, et al
    Lipopolysaccharide induces platelet activation in HIV patients: the role of different viral load patterns.
    HIV Med. 2021 Jan 10. doi: 10.1111/hiv.13059.
    >> Share

  72. XU X, Lin H, Chen X, Zhu B, et al
    Differences in hypertension and prehypertension among people living with and without HIV in China: role of HIV infection and antiretroviral therapy.
    HIV Med. 2021 Jan 9. doi: 10.1111/hiv.13040.
    >> Share

  73. HORN C, Augustin M, Ercanoglu MS, Heger E, et al
    HIV DNA reservoir and elevated PD-1 expression of CD4 T-cell subsets particularly persist in the terminal ileum of HIV-positive patients despite cART.
    HIV Med. 2021 Jan 9. doi: 10.1111/hiv.13031.
    >> Share

  74. JABLONOWSKA E, Szetela B, Bielecki M, Horban A, et al
    Acquired immune deficiency syndrome (AIDS) and late presentation in Poland - data from Test and Keep in Care (TAK) Polska project.
    HIV Med. 2021 Jan 6. doi: 10.1111/hiv.13041.
    >> Share


  75. British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of Candidiasis 2019.
    HIV Med. 2021;22:73.
    >> Share

    December 2020
  76. HOFFMANN C, Casado JL, Harter G, Vizcarra P, et al
    Immune deficiency is a risk factor for severe COVID-19 in people living with HIV.
    HIV Med. 2020 Dec 27. doi: 10.1111/hiv.13037.
    >> Share

  77. GONZALEZ-SERNA A, Macias J, Palacios R, Gomez-Ayerbe C, et al
    Incidence of recently acquired hepatitis C virus infection among HIV-infected patients in southern Spain.
    HIV Med. 2020 Dec 26. doi: 10.1111/hiv.13039.
    >> Share

  78. BAXTER JD, Dunn D, Tostevin A, Marvig RL, et al
    Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study.
    HIV Med. 2020 Dec 25. doi: 10.1111/hiv.13038.
    >> Share

  79. REICHMUTH ML, Chaudron SE, Bachmann N, Nguyen H, et al
    Using longitudinally sampled viral nucleotide sequences to characterize the drivers of HIV-1 transmission.
    HIV Med. 2020 Dec 25. doi: 10.1111/hiv.13030.
    >> Share

  80. MCLEOD A, Hutchinson SJ, Smith S, Leen C, et al
    Increased case-finding and uptake of direct-acting antiviral treatment essential for micro-elimination of hepatitis C among people living with HIV: a national record linkage study.
    HIV Med. 2020 Dec 17. doi: 10.1111/hiv.13032.
    >> Share

  81. FIGUEROA MI, Camiro-Zuniga A, Belaunzaran-Zamudio PF, Sierra Madero J, et al
    The effect of protease inhibitor-based dual antiretroviral regimens on CD4/CD8 ratio during the first year of therapy in ART-naive patients with HIV-infection.
    HIV Med. 2020 Dec 17. doi: 10.1111/hiv.13008.
    >> Share

  82. BOGORODSKAYA M, Lyass A, Mahoney TF, Borowsky LH, et al
    Utilization of absolute monocyte counts to predict cardiovascular events in people living with HIV.
    HIV Med. 2020 Dec 8. doi: 10.1111/hiv.13018.
    >> Share

  83. TIAN Q, Si J, Jiang F, Xu R, et al
    Caspofungin combined with TMP/SMZ as a first-line therapy for moderate-to-severe PCP in patients with human immunodeficiency virus infection.
    HIV Med. 2020 Dec 4. doi: 10.1111/hiv.13013.
    >> Share

  84. HIREMATH PG, Bhondoekhan F, Haberlen SA, Ashikaga H, et al
    Testosterone use and shorter electrocardiographic QT interval duration in men living with and without HIV.
    HIV Med. 2020 Dec 3. doi: 10.1111/hiv.13029.
    >> Share

  85. CHADWICK DR, Sutherland RK, Raffe S, Pool E, et al
    British HIV Association guidelines on the management of opportunistic infection in people living with HIV: the clinical management of gastrointestinal opportunistic infections 2020.
    HIV Med. 2020;21 Suppl 5:1-19.
    >> Share

  86. PALFREEMAN A, Sullivan A, Rayment M, Waters L, et al
    British HIV Association/British Association for Sexual Health and HIV/British Infection Association adult HIV testing guidelines 2020.
    HIV Med. 2020;21 Suppl 6:1-26.
    >> Share

  87. LIU JY, Sun LQ, Hou YY, Wang LF, et al
    Barriers to early diagnosis and treatment of severely immunosuppressed patients with HIV-1 infection: A quantitative and qualitative study.
    HIV Med. 2020;21:708-717.
    >> Share

  88. HU W, Jiao YM, Wang FS
    Snapshot of clinical studies on people living with HIV in China.
    HIV Med. 2020;21:681-682.
    >> Share

  89. YING RS, Le T, Cai WP, Li YR, et al
    Clinical epidemiology and outcome of HIV-associated talaromycosis in Guangdong, China, during 2011-2017.
    HIV Med. 2020;21:729-738.
    >> Share

  90. ZHAO Y, Han MJ, Gan XM, Ma Y, et al
    Characteristics and viral suppression among people living with HIV from the National Free Antiretroviral Therapy Programme, 2019.
    HIV Med. 2020;21:701-707.
    >> Share

  91. QI TK, Chen J, Zhang RF, Liu L, et al
    A retrospective cohort study of early mortality among patients with HIV/TB co-infection in Shanghai municipality.
    HIV Med. 2020;21:739-746.
    >> Share

  92. ZHANG C, Hu W, Jin JH, Zhou MJ, et al
    The role of CD8 T cells in controlling HIV beyond the antigen-specific face.
    HIV Med. 2020;21:692-700.
    >> Share

  93. LIU A, Zhang L, Zhang X, Zhang HW, et al
    Delayed seroreversion of specifical antibody against HIV in HIV-exposed infants: A retrospective cohort study.
    HIV Med. 2020;21:718-721.
    >> Share

  94. LIN L, Li TS
    Multidisciplinary collaborative integrated management of increasingly prominent HIV complications in the post-cART era.
    HIV Med. 2020;21:683-691.
    >> Share

  95. LI JH, Ma J, Kang W, Wang CF, et al
    The histone deacetylase inhibitor chidamide induces intermittent viraemia in HIV-infected patients on suppressive antiretroviral therapy.
    HIV Med. 2020;21:747-757.
    >> Share

  96. JIANG TY, Hou JH, Su B, Zhang T, et al
    Demographic and clinical factors associated with immune reconstitution in HIV/HBV co-infected and HIV mono-infected patients: a retrospective cohort study.
    HIV Med. 2020;21:722-728.
    >> Share

    November 2020
  97. HSU R, Brunet L, Fusco J, Beyer A, et al
    Risk of chronic kidney disease in people living with HIV by tenofovir disoproxil fumarate (TDF) use and baseline D:A:D chronic kidney disease risk score.
    HIV Med. 2020 Nov 28. doi: 10.1111/hiv.13019.
    >> Share

  98. SIVARAJ V, Cliff P, Douthwaite S, Smith M, et al
    Pneumocystis jirovecii pneumonia PCR test on upper respiratory tract swab.
    HIV Med. 2020 Nov 23. doi: 10.1111/hiv.13014.
    >> Share

  99. BENTZON AK, Panteleev A, Mitsura V, Borodulina E, et al
    Healthcare delivery for HIV-positive people with tuberculosis in Europe.
    HIV Med. 2020 Nov 20. doi: 10.1111/hiv.13016.
    >> Share

  100. HAN WM, Jiamsakul A, Jantarapakde J, Yunihastuti E, et al
    Association of body mass index with immune recovery, virological failure and cardiovascular disease risk among people living with HIV.
    HIV Med. 2020 Nov 17. doi: 10.1111/hiv.13017.
    >> Share

  101. CUI Z, Huang H, Zhang T, Yu Z, et al
    Low awareness of and willingness to use PrEP in the Chinese YMSM: An alert in YMSM HIV prevention.
    HIV Med. 2020 Nov 16. doi: 10.1111/hiv.12990.
    >> Share

  102. SANMARTI M, Meyer AC, Jaen A, Robertson K, et al
    HIV-associated neurocognitive impairment in stable people living with HIV on ART in rural Tanzania.
    HIV Med. 2020 Nov 15. doi: 10.1111/hiv.12979.
    >> Share

  103. TRICKEY A, Stone J, Semchuk N, Saliuk T, et al
    Is contact between men who have sex with men and non-governmental organizations providing harm reduction associated with improved HIV outcomes?
    HIV Med. 2020 Nov 12. doi: 10.1111/hiv.13010.
    >> Share

  104. SARFO FS, Norman B, Nichols M, Appiah L, et al
    Prevalence and incidence of pre-diabetes and diabetes mellitus among people living with HIV in Ghana: Evidence from the EVERLAST Study.
    HIV Med. 2020 Nov 10. doi: 10.1111/hiv.13007.
    >> Share

  105. HANTTU A, Kauppinen KJ, Kivela P, Ollgren J, et al
    Prevalence of obesity and disturbances in glucose homeostasis in HIV-infected subjects and general population - missed diagnoses of diabetes?
    HIV Med. 2020 Nov 9. doi: 10.1111/hiv.13009.
    >> Share

  106. CHOUDHURY B, Brown J, Ransy DG, Brophy J, et al
    Endothelial activation is associated with intestinal epithelial injury, systemic inflammation and treatment regimen in children living with vertically acquired HIV-1 infection.
    HIV Med. 2020 Nov 5. doi: 10.1111/hiv.13012.
    >> Share

  107. BEANLAND A, Alagaratnam J, Goffe C, Bailey A, et al
    Objective and subjective rapid frailty screening tools in people with HIV.
    HIV Med. 2020 Nov 5. doi: 10.1111/hiv.12988.
    >> Share

  108. ROSS J, Jiamsakul A, Kumarasamy N, Azwa I, et al
    Virological failure and HIV drug resistance among adults living with HIV on second-line antiretroviral therapy in the Asia-Pacific.
    HIV Med. 2020 Nov 5. doi: 10.1111/hiv.13006.
    >> Share

  109. MORKPHROM E, Ratanasuwan W, Sittironnarit G, Rattanaumpawan P, et al
    Non-disclosure of HIV serostatus to sexual partners: Prevalence, risk factors and clinical impact in patients with HIV.
    HIV Med. 2020 Nov 3. doi: 10.1111/hiv.13005.
    >> Share

  110. PODA A, Kabore NF, Malateste K, De Rekeneire N, et al
    Validation of the D:A:D chronic kidney disease risk score in people living with HIV: the IeDEA West Africa Cohort Collaboration.
    HIV Med. 2020 Nov 3. doi: 10.1111/hiv.12982.
    >> Share

  111. TO KW, Lee SS
    A review of reported cases of HIV pre-exposure prophylaxis failure with resultant breakthrough HIV infections.
    HIV Med. 2020 Nov 3. doi: 10.1111/hiv.12989.
    >> Share


  112. Abstracts of the 26th Annual Conference of the British HIV Association (BHIVA), Digital Conference, 22nd-24th November 2020.
    HIV Med. 2020;21 Suppl 4:3-74.
    >> Share

    October 2020
  113. PAUL G, Wesselmann J, Adzic D, Malin JJ, et al
    Predictors of serofast state after treatment for early syphilis in HIV-infected patients.
    HIV Med. 2020 Oct 30. doi: 10.1111/hiv.12985.
    >> Share

  114. FREGUJA R, Bamford A, Zanchetta M, Del Bianco P, et al
    Long-term clinical, virological and immunological outcomes following planned treatment interruption in HIV-infected children.
    HIV Med. 2020 Oct 29. doi: 10.1111/hiv.12986.
    >> Share

  115. FERNANDEZ I, de Lazzari E, Inciarte A, Diaz-Brito V, et al
    Network meta-analysis of post-exposure prophylaxis randomized clinical trials.
    HIV Med. 2020 Oct 27. doi: 10.1111/hiv.12964.
    >> Share

  116. MCALLISTER S, van Asten H, Anglemyer A, Crengle S, et al
    Cascade of care of people diagnosed with HIV in New Zealand between 2006 and 2017.
    HIV Med. 2020 Oct 27. doi: 10.1111/hiv.12983.
    >> Share

  117. KIRWAN PD, Hibbert M, Kall M, Nambiar K, et al
    HIV prevalence and HIV clinical outcomes of transgender and gender-diverse people in England.
    HIV Med. 2020 Oct 26. doi: 10.1111/hiv.12987.
    >> Share

  118. AUNG HL, Bloch M, Vincent T, Quan D, et al
    Cognitive ageing is premature among a community sample of optimally treated people living with HIV.
    HIV Med. 2020 Oct 21. doi: 10.1111/hiv.12980.
    >> Share

  119. GAZZOLA L, Tagliaferri G, De Bona A, Mondatore D, et al
    Dyslipidaemia after switch to tenofovir alafenamide (TAF)-based cART regimens in a cohort of HIV-positive patients: what clinical relevance?
    HIV Med. 2020 Oct 21. doi: 10.1111/hiv.12984.
    >> Share

  120. QUAH SP, McIntyre M, Wood A, Mc Mullan K, et al
    Once-daily raltegravir with tenofovir disoproxil/emtricitabine as HIV post-exposure prophylaxis following sexual exposure.
    HIV Med. 2020 Oct 16. doi: 10.1111/hiv.12938.
    >> Share

  121. SCHUETTFORT G, Boekenkamp L, Cabello A, Cotter AG, et al
    Antiretroviral treatment outcomes among late HIV presenters initiating treatment with integrase inhibitors or protease inhibitors.
    HIV Med. 2020 Oct 13. doi: 10.1111/hiv.12962.
    >> Share

  122. WENGER DS, Triplette M, Shahrir S, Akgun KM, et al
    Associations of marijuana with markers of chronic lung disease in people living with HIV.
    HIV Med. 2020 Oct 6. doi: 10.1111/hiv.12966.
    >> Share

  123. VAUGHAN J, Perner Y, Mayne E, Wiggill T, et al
    Plasmablastic lymphoma in Johannesburg, South Africa, in the era of widescale antiretroviral therapy use.
    HIV Med. 2020 Oct 6. doi: 10.1111/hiv.12965.
    >> Share

  124. BALAYAN T, Begovac J, Skrzat-Klapaczynska A, Aho I, et al
    Where are we with pre-exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group.
    HIV Med. 2020 Oct 5. doi: 10.1111/hiv.12960.
    >> Share

  125. ALMEIDA F, Macedo A, Trigo D, Abreu M, et al
    Neurocognitive evaluation using the International HIV Dementia Scale (IHDS) and Montreal Cognitive Assessment Test (MoCA) in an HIV-2 population.
    HIV Med. 2020 Oct 4. doi: 10.1111/hiv.12963.
    >> Share

  126. BLOCH M, John M, Smith D, Rasmussen TA, et al
    Managing HIV-associated inflammation and ageing in the era of modern ART.
    HIV Med. 2020;21 Suppl 3:2-16.
    >> Share

  127. IBRAHIM F, Campbell L, Bailey AC, Stockwell S, et al
    Estimated glomerular filtration rate slopes on tenofovir alafenamide.
    HIV Med. 2020;21:607-612.
    >> Share

  128. DRAVID A, Betha TP, Sharma AK, Gawali R, et al
    Efficacy and safety of a single-tablet regimen containing tenofovir disoproxil fumarate 300 mg, lamivudine 300 mg and efavirenz 400 mg as a switch strategy in virologically suppressed HIV-1-infected subjects on nonnucleoside reverse transcriptase inhi
    HIV Med. 2020;21:578-587.
    >> Share

    September 2020
  129. IBRAHIM F, Samarawickrama A, Hamzah L, Vincent R, et al
    Bone mineral density, kidney function, weight gain and insulin resistance in women who switch from TDF/FTC/NNRTI to ABC/3TC/DTG.
    HIV Med. 2020 Sep 27. doi: 10.1111/hiv.12961.
    >> Share

  130. BASIL RC, Brown TT, Haberlen S, Rubin LH, et al
    The relationship between diabetes and depressive symptoms in men with or at risk of HIV infection.
    HIV Med. 2020 Sep 24. doi: 10.1111/hiv.12958.
    >> Share

  131. BORGHETTI A, Ciccullo A, Lombardi F, Baldin G, et al
    Transmitted drug resistance to NRTIs and risk of virological failure in naive patients treated with integrase inhibitors.
    HIV Med. 2020 Sep 23. doi: 10.1111/hiv.12956.
    >> Share

  132. ADAMS JL, Murray M, Patel N, Sawkin MT, et al
    Comparative effectiveness of antiretroviral drug classes for the treatment of HIV infection in patients with high viral loads: a multicentre retrospective cohort study.
    HIV Med. 2020 Sep 23. doi: 10.1111/hiv.12959.
    >> Share

  133. KORTEN V, Ay U, Hari E, Tigen Tukenmez E, et al
    Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
    HIV Med. 2020 Sep 23. doi: 10.1111/hiv.12957.
    >> Share

  134. ATIM M, Girometti N, Hyndman I, McOwan A, et al
    Post-exposure prophylaxis in the era of pre-exposure prophylaxis.
    HIV Med. 2020 Sep 9. doi: 10.1111/hiv.12917.
    >> Share

  135. KREBS-DEMMER L, Ronit A, Sigvardsen PE, Lebech AM, et al
    Cardiac chamber volumes and left ventricular mass in people living with HIV and matched uninfected controls.
    HIV Med. 2020 Sep 9. doi: 10.1111/hiv.12916.
    >> Share

  136. HSU D, Ruf M, Leong G, Douthwaite S, et al
    The London Initiative for Glandular Fever HIV Testing (LIGHT) initiative: integration of opt-out HIV tests in primary care glandular fever serology order-sets - simple, effective and sustainable increase in HIV testing in line with UK and European gui
    HIV Med. 2020 Sep 7. doi: 10.1111/hiv.12914.
    >> Share

  137. SABIN CA, Kunisaki KM, Bagkeris E, Post FA, et al
    Respiratory symptoms and chronic bronchitis in people with and without HIV infection.
    HIV Med. 2020 Sep 6. doi: 10.1111/hiv.12955.
    >> Share

  138. BLEASEL JM, Heron JE, Shamu T, Chimbetete C, et al
    Body mass index and noninfectious comorbidity in HIV-positive patients commencing antiretroviral therapy in Zimbabwe.
    HIV Med. 2020 Sep 6. doi: 10.1111/hiv.12934.
    >> Share

  139. LATINI A, Dona MG, Giuliani M, Magri F, et al
    Implications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic for sexual behaviours of men who have sex with men.
    HIV Med. 2020 Sep 6. doi: 10.1111/hiv.12954.
    >> Share

  140. RYAN KE, Wiggins J, Higgins N, El-Hayek C, et al
    Improved capture of trans and gender-diverse people diagnosed with HIV infection in Victoria following refinement to notification form.
    HIV Med. 2020 Sep 6. doi: 10.1111/hiv.12915.
    >> Share

  141. RYOM L, Cotter A, De Miguel R, Beguelin C, et al
    2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0.
    HIV Med. 2020 Sep 3. doi: 10.1111/hiv.12878.
    >> Share

  142. GHEIBI Z, Dianatinasab M, Haghparast A, Mirzazadeh A, et al
    Gender difference in all-cause mortality of people living with HIV in Iran: findings from a 20-year cohort study.
    HIV Med. 2020 Sep 2. doi: 10.1111/hiv.12940.
    >> Share

  143. CICCULLO A, Borghetti A, Dusina A, Segala FV, et al
    The need to continue testing for HIV, even during the coronavirus disease 2019 (COVID-19) pandemic.
    HIV Med. 2020 Sep 2. doi: 10.1111/hiv.12936.
    >> Share

  144. ANDRADE HB, da Silva I, Ramos GV, Medeiros DM, et al
    Short- and medium-term prognosis of HIV-infected patients receiving intensive care: a Brazilian multicentre prospective cohort study.
    HIV Med. 2020 Sep 2. doi: 10.1111/hiv.12939.
    >> Share

  145. TABORELLI M, Suligoi B, Toffolutti F, Frova L, et al
    Excess liver-related mortality among people with AIDS compared to the general population: an Italian nationwide cohort study using multiple causes of death.
    HIV Med. 2020 Sep 2. doi: 10.1111/hiv.12937.
    >> Share

  146. LEEME TB, Mine M, Lechiile K, Mulenga F, et al
    Utility of CD4 count measurement in the era of universal antiretroviral therapy: an analysis of routine laboratory data in Botswana.
    HIV Med. 2020 Sep 2. doi: 10.1111/hiv.12951.
    >> Share

  147. BOEKE CE, Khan S, Walsh F, Hettema A, et al
    Universal test and treat in relation to HIV disease progression: results from a stepped-wedge trial in Eswatini.
    HIV Med. 2020 Sep 2. doi: 10.1111/hiv.12941.
    >> Share

  148. D'ARMINIO MONFORTE A, Bonnet F, Bucher HC, Pourcher V, et al
    What do the changing patterns of comorbidity burden in people living with HIV mean for long-term management? Perspectives from European HIV cohorts.
    HIV Med. 2020;21 Suppl 2:3-16.
    >> Share

  149. GIROMETTI N, Lander F, McOwan A, Nwokolo N, et al
    Rapid ART start in early HIV infection: Time to viral load suppression and retention in care in a London cohort.
    HIV Med. 2020 Sep 1. doi: 10.1111/hiv.12900.
    >> Share

    August 2020
  150. MIYASHITA H, Kuno T
    Prognosis of coronavirus disease 2019 (COVID-19) in patients with HIV infection in New York City.
    HIV Med. 2020 Aug 23. doi: 10.1111/hiv.12920.
    >> Share

  151. RODGER AJ, Dunn D, McCabe L, Weatherburn P, et al
    Sexual risk and HIV testing disconnect in men who have sex with men (MSM) recruited to an online HIV self-testing trial.
    HIV Med. 2020 Aug 9. doi: 10.1111/hiv.12919.
    >> Share

  152. TUN N, Mclean A, Deed X, Hlaing M, et al
    Is stopping secondary prophylaxis safe in HIV-positive talaromycosis patients? Experience from Myanmar.
    HIV Med. 2020 Aug 1. doi: 10.1111/hiv.12921.
    >> Share

  153. MARTIN T, Gianella S, Franklin D, Hsue P, et al
    Methamphetamine and cardiac disease among people with HIV infection.
    HIV Med. 2020 Aug 1. doi: 10.1111/hiv.12918.
    >> Share

    July 2020
  154. TUN NN, McLean A, Wilkins E, Hlaing M, et al
    Integration of HIV services with primary care in Yangon, Myanmar: a retrospective cohort analysis.
    HIV Med. 2020 Jul 20. doi: 10.1111/hiv.12886.
    >> Share

  155. COOPER TJ, Woodward BL, Alom S, Harky A, et al
    Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: a systematic review.
    HIV Med. 2020 Jul 15. doi: 10.1111/hiv.12911.
    >> Share

  156. OKOLI C, Schwenk A, Radford M, Myland M, et al
    Polypharmacy and potential drug-drug interactions for people with HIV in the UK from the Climate-HIV database.
    HIV Med. 2020 Jul 15. doi: 10.1111/hiv.12879.
    >> Share

  157. VAN BECKHOVEN D, Florence E, De Wit S, Wyndham-Thomas C, et al
    Incidence rate, predictors and outcomes of interruption of HIV care: nationwide results from the Belgian HIV cohort.
    HIV Med. 2020 Jul 5. doi: 10.1111/hiv.12901.
    >> Share

    June 2020
  158. MOCROFT A
    Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naive persons starting treatment.
    HIV Med. 2020 Jun 26. doi: 10.1111/hiv.12888.
    >> Share

  159. TARAMASSO L, Fabbiani M, Nozza S, De Benedetto I, et al
    Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort.
    HIV Med. 2020 Jun 24. doi: 10.1111/hiv.12885.
    >> Share

  160. MWASAKIFWA GE, Amin J, White CP, Center JR, et al
    Early changes in bone turnover and inflammatory biomarkers and clinically significant bone mineral density loss over 48 weeks among HIV-infected patients with virological failure of a standard first-line antiretroviral therapy regimen in the SECOND-LI
    HIV Med. 2020 Jun 23. doi: 10.1111/hiv.12882.
    >> Share

  161. GANTNER P, Allavena C, Duvivier C, Cabie A, et al
    Post-exposure prophylaxis completion and condom use in the context of potential sexual exposure to HIV.
    HIV Med. 2020 Jun 17. doi: 10.1111/hiv.12880.
    >> Share

  162. SCHRADER SY, Zeder AJ, Hilge R, Bogner JR, et al
    Medium-grade proteinuria is a risk factor for incident markers of chronic kidney disease.
    HIV Med. 2020 Jun 17. doi: 10.1111/hiv.12881.
    >> Share

  163. MCMILLAN JM, Gill MJ, Rubin LH
    Distinct risks, clinical characteristics and outcomes by age at time of HIV diagnosis.
    HIV Med. 2020 Jun 16. doi: 10.1111/hiv.12887.
    >> Share

  164. WATERS L, Rockstroh JK
    Antiretroviral HIV drugs in COVID-19 research: promises and risks. An opinion piece.
    HIV Med. 2020 Jun 16. doi: 10.1111/hiv.12913.
    >> Share

  165. LOPEZ-CENTENO B, Badenes-Olmedo C, Mataix-Sanjuan A, Bellon JM, et al
    Potentially inappropriate medications in older adults living with HIV.
    HIV Med. 2020 Jun 9. doi: 10.1111/hiv.12883.
    >> Share

  166. BIANCONI V, Schiaroli E, Pirro M, Cardaci S, et al
    Effects of antiretroviral therapy on proprotein convertase subtilisin/kexin 9: focus on lipids, inflammation and immunovirological parameters.
    HIV Med. 2020 Jun 4. doi: 10.1111/hiv.12884.
    >> Share

  167. IWUJI CC, Shahmanesh M, Koole O, Herbst K, et al
    Clinical outcomes after first-line HIV treatment failure in South Africa: the next cascade of care.
    HIV Med. 2020 Jun 3. doi: 10.1111/hiv.12877.
    >> Share

    May 2020
  168. CHAO A, Spiegelman D, Khan S, Walsh F, et al
    Mortality under early access to antiretroviral therapy vs. Eswatini's national standard of care: the MaxART clustered randomized stepped-wedge trial.
    HIV Med. 2020 May 26. doi: 10.1111/hiv.12876.
    >> Share

  169. WINSTON A, Cotter A, Gisslen M, Mallon P, et al
    Response to: 'How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?'
    HIV Med. 2020 May 22. doi: 10.1111/hiv.12874.
    >> Share

  170. HINDOCHA A, Randell P, Seery P, Rahimi T, et al
    The optimal time to test for sero-reversion in HIV-exposed uninfected infants: the later the better?
    HIV Med. 2020 May 22. doi: 10.1111/hiv.12862.
    >> Share

  171. DARLING K, Metral M, Du Pasquier R, Cavassini M, et al
    Authors' reply to A. Winston, A. Cotter, M. Gisslen, P. W. G. Mallon and P. Cinque.
    HIV Med. 2020 May 18. doi: 10.1111/hiv.12875.
    >> Share

    April 2020
  172. SAVINELLI S, De Francesco D, Feeney ER, Babalis D, et al
    Factors associated with obesity in the Pharmacokinetic and Clinical Observations in People over Fifty (POPPY) cohort: an observational cross-sectional analysis.
    HIV Med. 2020 Apr 20. doi: 10.1111/hiv.12857.
    >> Share

  173. DAVARI M, Giwa HB, Nabizade A, Taheri F, et al
    Antiretroviral therapy and the risk of sexual transmission of HIV: a systematic review and meta-analysis.
    HIV Med. 2020 Apr 20. doi: 10.1111/hiv.12841.
    >> Share

  174. LEVY ME, Monroe AK, Horberg MA, Benator DA, et al
    Is low-level viraemia associated with serum lipid profiles among HIV controllers?
    HIV Med. 2020 Apr 20. doi: 10.1111/hiv.12856.
    >> Share

    March 2020
  175. RUSSELL E, Albert A, Cote H, Hsieh A, et al
    Rate of dyslipidemia higher among women living with HIV: A comparison of metabolic and cardiovascular health in a cohort to sutdy aging in HIV.
    HIV Med. 2020 Mar 13. doi: 10.1111/hiv.12843.
    >> Share

  176. EKONG N, Curtis H, Ong E, Sabin CA, et al
    Monitoring of older HIV-1-positive adults by HIV clinics in the United Kingdom: a national quality improvement initiative.
    HIV Med. 2020 Mar 3. doi: 10.1111/hiv.12842.
    >> Share

  177. STELLBRINK HJ, Lazzarin A, Woolley I, Llibre JM, et al
    The potential role of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) single-tablet regimen in the expanding spectrum of fixed-dose combination therapy for HIV.
    HIV Med. 2020;21 Suppl 1:3-16.
    >> Share

    February 2020
  178. SCHWARZE-ZANDER C, Piduhn H, Boesecke C, Schlabe S, et al
    Switching tenofovir disoproxil fumarate to tenofovir alafenamide in a real life setting: what are the implications?
    HIV Med. 2020 Feb 17. doi: 10.1111/hiv.12840.
    >> Share

    January 2020
  179. MILLS AM, Schulman KL, Fusco JS, Brunet L, et al
    Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) chronic kidney disease risk score in HIV-infected patients in the USA.
    HIV Med. 2020 Jan 27. doi: 10.1111/hiv.12826.
    >> Share

  180. STIRRUP OT, Asboe D, Pozniak A, Sabin CA, et al
    Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV-1 resistance mutation.
    HIV Med. 2020 Jan 11. doi: 10.1111/hiv.12829.
    >> Share

  181. FREEMAN-ROMILLY N, Nyatsanza F, Namiba A, Lyall H, et al
    Moving closer to what women want? A review of breastfeeding and women living with HIV in the UK and high-income countries.
    HIV Med. 2020;21:1-8.
    >> Share

    December 2019
  182. BLANCO JR, Romero L, Ramalle-Gomara E, Metola L, et al
    Retinol-binding protein 4 (RBP4), a potential biomarker of frailty in HIV-infected people on stable antiretroviral therapy.
    HIV Med. 2019 Dec 29. doi: 10.1111/hiv.12837.
    >> Share

  183. NOE S, Jonsson-Oldenbuettel C, Jaeger H
    Not all is perfect with Tenofovir alafenamide.
    HIV Med. 2019 Dec 29. doi: 10.1111/hiv.12832.
    >> Share

  184. METRAL M, Nadin I, Locatelli I, Tarr PE, et al
    How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?
    HIV Med. 2019 Dec 27. doi: 10.1111/hiv.12828.
    >> Share

  185. COOK RR, Fulcher JA, Tobin NH, Li F, et al
    Combined effects of HIV and obesity on the gastrointestinal microbiome of young men who have sex with men.
    HIV Med. 2019 Dec 27. doi: 10.1111/hiv.12838.
    >> Share

  186. BLACKMAN AL, Pandit NS, Pincus KJ
    Comparing rates of statin therapy in eligible patients living with HIV versus uninfected patients.
    HIV Med. 2019 Dec 25. doi: 10.1111/hiv.12794.
    >> Share

  187. LIANG Y, Han Z, Shui J, Cheng W, et al
    HIV-1 genotype is independently associated with immunodeficiency progression among Chinese men who have sex with men: an observational cohort study.
    HIV Med. 2019 Dec 21. doi: 10.1111/hiv.12823.
    >> Share

  188. MAPHULA RW, Laher AE, Richards GA
    Patterns of presentation and survival of HIV-infected patients admitted to a tertiary-level intensive care unit.
    HIV Med. 2019 Dec 20. doi: 10.1111/hiv.12834.
    >> Share

  189. KRENTZ HB, Vu Q, Gill MJ
    Updated direct costs of medical care for HIV-infected patients within a regional population from 2006 to 2017.
    HIV Med. 2019 Dec 18. doi: 10.1111/hiv.12824.
    >> Share

  190. ROOZEN G, Vos AG, Tempelman HA, Venter W, et al
    Cardiovascular disease risk and its determinants in people living with HIV across different settings in South Africa.
    HIV Med. 2019 Dec 18. doi: 10.1111/hiv.12831.
    >> Share

  191. RUPASINGHE D, Kiertiburanakul S, Kamarulzaman A, Zhang F, et al
    Early mortality after late initiation of antiretroviral therapy in the TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia-Pacific.
    HIV Med. 2019 Dec 18. doi: 10.1111/hiv.12836.
    >> Share

  192. SHAFRAN SD, Di Perri G
    Response to Noe, Oldenbuettel and Jaeger.
    HIV Med. 2019 Dec 18. doi: 10.1111/hiv.12835.
    >> Share

  193. CHAZOT R, Botelho-Nevers E, Fresard A, Lucht F, et al
    Chronic kidney disease is highly prevalent in people living with HIV in a mainly Caucasian European cohort.
    HIV Med. 2019 Dec 18. doi: 10.1111/hiv.12827.
    >> Share

  194. HAMPEL B, Kusejko K, Kouyos RD, Boni J, et al
    Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017.
    HIV Med. 2019 Dec 18. doi: 10.1111/hiv.12821.
    >> Share

  195. WANG X, Tang Z, Wu Z, Nong Q, et al
    Promoting oral HIV self-testing via the internet among men who have sex with men in China: a feasibility assessment.
    HIV Med. 2019 Dec 18. doi: 10.1111/hiv.12830.
    >> Share

  196. WITZEL TC, Bourne A, Burns FM, Rodger AJ, et al
    HIV self-testing intervention experiences and kit usability: results from a qualitative study among men who have sex with men in the SELPHI (Self-Testing Public Health Intervention) randomized controlled trial in England and Wales.
    HIV Med. 2019 Dec 10. doi: 10.1111/hiv.12818.
    >> Share

    November 2019
  197. SADRI NAHAND J, Bokharaei-Salim F, Karimzadeh M, Moghoofei M, et al
    MicroRNAs and exosomes: key players in HIV pathogenesis.
    HIV Med. 2019 Nov 22. doi: 10.1111/hiv.12822.
    >> Share

  198. PEREIRA IO, Pascom A, Mosimann G, Barros Perini F, et al
    Post-exposure prophylaxis following consented sexual exposure: impact of national recommendations on user profile, drug regimens and estimates of averted HIV infections.
    HIV Med. 2019 Nov 15. doi: 10.1111/hiv.12825.
    >> Share

  199. MAKINSON A, Tron L, Grabar S, Milleron B, et al
    Potential lung cancer screening outcomes using different age and smoking thresholds in the ANRS-CO4 French Hospital Database on HIV cohort.
    HIV Med. 2019 Nov 15. doi: 10.1111/hiv.12811.
    >> Share

  200. DESAI S, Tavoschi L, Sullivan AK, Combs L, et al
    HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review.
    HIV Med. 2019 Nov 14. doi: 10.1111/hiv.12809.
    >> Share

  201. BRUSCA RM, Hanna DB, Wada NI, Blankson JN, et al
    Subclinical cardiovascular disease in HIV controller and long-term nonprogressor populations.
    HIV Med. 2019 Nov 14. doi: 10.1111/hiv.12820.
    >> Share

  202. SUAREZ-GARCIA I, Alejos B, Delgado E, Rivero M, et al
    How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain.
    HIV Med. 2019 Nov 8. doi: 10.1111/hiv.12817.
    >> Share

  203. CROXFORD S, Tavoschi L, Sullivan AK, Combs L, et al
    HIV testing strategies outside of health care settings in the European Union (EU)/European Economic Area (EEA): a systematic review to inform European Centre for Disease Prevention and Control guidance.
    HIV Med. 2019 Nov 4. doi: 10.1111/hiv.12807.
    >> Share

  204. HAMZAH L, Williams D, Bailey AC, Jones R, et al
    Early safety of tenofovir alafenamide in patients with a history of tubulopathy on tenofovir disoproxil fumarate: a randomized controlled clinical trial.
    HIV Med. 2019 Nov 3. doi: 10.1111/hiv.12819.
    >> Share


  205. Abstracts of the 17th European AIDS Conference, Basel, Switzerland, 6-9 November 2019.
    HIV Med. 2019;20 Suppl 9:3-316.
    >> Share

    October 2019
  206. YANG X, Li X, Qiao S
    Patterns of comorbidity and sociodemographic and psychosocial correlates among people living with HIV in South Carolina, USA.
    HIV Med. 2019 Oct 30. doi: 10.1111/hiv.12812.
    >> Share

  207. LAUT K, Kirk O, Rockstroh J, Phillips A, et al
    The EuroSIDA study: 25 years of scientific achievements.
    HIV Med. 2019 Oct 24. doi: 10.1111/hiv.12810.
    >> Share

  208. SEBASTIANI G, Cocciolillo S, Mazzola G, Malagoli A, et al
    Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV-monoinfected patients.
    HIV Med. 2019 Oct 23. doi: 10.1111/hiv.12799.
    >> Share

  209. CARR A, Grund B, Schwartz AV, Avihingsanon A, et al
    The rate of bone loss slows after 1-2 years of initial antiretroviral therapy: final results of the Strategic Timing of Antiretroviral Therapy(START) bone mineral density substudy.
    HIV Med. 2019 Oct 23. doi: 10.1111/hiv.12796.
    >> Share

  210. DIRAJLAL-FARGO S, Shan L, Sattar A, Bowman E, et al
    Insulin resistance and intestinal integrity in children with and without HIV infection in Uganda.
    HIV Med. 2019 Oct 23. doi: 10.1111/hiv.12808.
    >> Share

  211. TCHIDJOU HK, Palandri L, Vescio FM, Pezzotti P, et al
    The unexposed world of the (HIV-negative) exposed.
    HIV Med. 2019 Oct 23. doi: 10.1111/hiv.12804.
    >> Share

  212. SERRAO A, Santoro C, Foa R, Chistolini A, et al
    Use of edoxaban for the treatment of venous thromboembolism in HIV-infected patients.
    HIV Med. 2019 Oct 16. doi: 10.1111/hiv.12803.
    >> Share

  213. FRANCIS-MORRIS A, Mackie NE, Eliahoo J, Ramzan F, et al
    Compromised CD4:CD8 ratio recovery in people living with HIV aged over 50 years: an observational study.
    HIV Med. 2019 Oct 16. doi: 10.1111/hiv.12800.
    >> Share

  214. RIPAMONTI E, Clerici M
    The association of memory disorders and chronic HIV disease in the antiretroviral therapy era: a systematic literature review.
    HIV Med. 2019 Oct 11. doi: 10.1111/hiv.12793.
    >> Share

  215. INCIARTE A, Leal L, Masfarre L, Gonzalez E, et al
    Post-exposure prophylaxis for HIV infection in sexual assault victims.
    HIV Med. 2019 Oct 11. doi: 10.1111/hiv.12797.
    >> Share

  216. ORBAEK M, Thorsteinsson K, Moseholm Larsen E, Katzenstein TL, et al
    Risk factors during pregnancy and birth-related complications in HIV-positive versus HIV-negative women in Denmark, 2002-2014.
    HIV Med. 2019 Oct 11. doi: 10.1111/hiv.12798.
    >> Share

  217. WILKINSON A, Quinn B, Draper B, White S, et al
    Prevalence of daily tobacco smoking participation among HIV-positive and HIV-negative Australian gay, bisexual and other men who have sex with men.
    HIV Med. 2019 Oct 11. doi: 10.1111/hiv.12802.
    >> Share

  218. METRAL M, Darling K, Locatelli I, Nadin I, et al
    The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile.
    HIV Med. 2019 Oct 7. doi: 10.1111/hiv.12795.
    >> Share

  219. BESUTTI G, Santoro A, Scaglioni R, Neri S, et al
    Significant chronic airway abnormalities in never-smoking HIV-infected patients.
    HIV Med. 2019 Oct 2. doi: 10.1111/hiv.12785.
    >> Share


  220. British HIV Association/British Infection Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of Candidiasis 2019.
    HIV Med. 2019;20 Suppl 8:2-24.
    >> Share

    September 2019
  221. ALEJOS B, Stella-Ascariz N, Montejano R, Rodriguez-Centeno J, et al
    Determinants of blood telomere length in antiretroviral treatment-naive HIV-positive participants enrolled in the NEAT 001/ANRS 143 clinical trial.
    HIV Med. 2019 Sep 18. doi: 10.1111/hiv.12791.
    >> Share

  222. SCHLAEPPI C, Vanobberghen F, Sikalengo G, Glass TR, et al
    Prevalence and management of drug-drug interactions with antiretroviral treatment in 2069 people living with HIV in rural Tanzania: a prospective cohort study.
    HIV Med. 2019 Sep 18. doi: 10.1111/hiv.12801.
    >> Share

    August 2019
  223. BAISLEY KJ, Seeley J, Siedner MJ, Koole K, et al
    Findings from home-based HIV testing and facilitated linkage after scale-up of test and treat in rural South Africa: young people still missing.
    HIV Med. 2019 Aug 27. doi: 10.1111/hiv.12787.
    >> Share

  224. BIRUNGI J, Cui Z, Okoboi S, Kapaata A, et al
    Lack of effectiveness of adherence counselling in reversing virological failure among patients on long-term antiretroviral therapy in rural Uganda.
    HIV Med. 2019 Aug 21. doi: 10.1111/hiv.12790.
    >> Share

  225. FALASCA K, Reale M, Di Nicola M, Ucciferri C, et al
    Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients.
    HIV Med. 2019 Aug 19. doi: 10.1111/hiv.12789.
    >> Share

  226. ASTILL N, Miall L, Shillito J, Winfield S, et al
    Managing women who decline HIV testing in pregnancy and their infants? A multidisciplinary team guideline.
    HIV Med. 2019 Aug 19. doi: 10.1111/hiv.12775.
    >> Share

  227. WHITLOCK G, Carbonell M, Blackwell S, Nwokolo N, et al
    Rapid initiation of antiretroviral therapy in those with newly diagnosed HIV infection in London, UK.
    HIV Med. 2019 Aug 19. doi: 10.1111/hiv.12780.
    >> Share

  228. BROGAN AJ, Talbird SE, Davis AE, Wild L, et al
    Is increased screening and early antiretroviral treatment for HIV-1 worth the investment? An analysis of the public health and economic impact of improvement in the UK.
    HIV Med. 2019 Aug 8. doi: 10.1111/hiv.12788.
    >> Share


  229. Corrigendum.
    HIV Med. 2019;20:496-499.
    >> Share

  230. MUKANYANGEZI MF, Rugwizangoga B, Manzi O, Rulisa S, et al
    Persistence rate of cervical human papillomavirus infections and abnormal cytology in Rwanda.
    HIV Med. 2019;20:485-495.
    >> Share

    July 2019
  231. SAUNDERS J, Mohammed H, Daskalopoulou M, Ogaz D, et al
    Response to: Fitzpatrick C, Lowe M, Richardson D. Sexually transmitted infection testing and rates in men who have sex with men (MSM) using HIV pre-exposure prophylaxis. HIV Medicine 2019; https://doi.org/10.1111/hiv.12736 (published Online First: 16
    HIV Med. 2019 Jul 31. doi: 10.1111/hiv.12776.
    >> Share

  232. FITZPATRICK C, Lowe M, Richardson D
    In response to Saunders et al RE: STI testing and rates in MSM using PrEP.
    HIV Med. 2019 Jul 31. doi: 10.1111/hiv.12774.
    >> Share

  233. MOHD SALLEH NA, Fairbairn N, Nolan S, Barrios R, et al
    Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.
    HIV Med. 2019 Jul 29. doi: 10.1111/hiv.12777.
    >> Share

  234. PETERSEN N, Knudsen AD, Mocroft A, Kirkegaard-Klitbo D, et al
    Prevalence of impaired renal function in virologically suppressed people living with HIV compared with controls: the Copenhagen Comorbidity in HIV Infection (COCOMO) study.
    HIV Med. 2019 Jul 29. doi: 10.1111/hiv.12778.
    >> Share

  235. BIJKER R, Kumarasamy N, Kiertiburanakul S, Pujari S, et al
    Diabetes, mortality and glucose monitoring rates in the TREAT Asia HIV Observational Database Low Intensity Transfer (TAHOD-LITE) study.
    HIV Med. 2019 Jul 23. doi: 10.1111/hiv.12779.
    >> Share

  236. TAN M, Johnston S, Nicholls J, Gompels M, et al
    Dual therapy with renally adjusted lamivudine and dolutegravir: a switch strategy to manage comorbidity and toxicity in older, suppressed patients?
    HIV Med. 2019 Jul 23. doi: 10.1111/hiv.12781.
    >> Share

  237. EMILIOZZI A, Ciccullo A, Borghetti A, Picarelli C, et al
    'How much raltegravir do you take?' The answer may not be so obvious: an accidental finding from clinical practice.
    HIV Med. 2019 Jul 23. doi: 10.1111/hiv.12783.
    >> Share

  238. CASADO JL, Monsalvo M, Vizcarra P, Fontecha M, et al
    Evaluation of kidney function in HIV-infected patients receiving an antiretroviral regimen containing one or two inhibitors of the tubular secretion of creatinine.
    HIV Med. 2019 Jul 19. doi: 10.1111/hiv.12784.
    >> Share

  239. CROXFORD S, Miller RF, Post FA, Harding R, et al
    Cause of death among HIV patients in London in 2016.
    HIV Med. 2019 Jul 5. doi: 10.1111/hiv.12761.
    >> Share

  240. DING Y, Duan S, Ye R, Yao S, et al
    Effects of aging, baseline renal function and stage of HIV infection on post-treatment changes in renal function among HIV-infected patients: a retrospective cohort study.
    HIV Med. 2019 Jul 5. doi: 10.1111/hiv.12763.
    >> Share

    June 2019
  241. SIWAK E, Horban A, Witak-Jedra M, Cielniak I, et al
    Long-term trends in HIV care entry: over 15 years of clinical experience from Poland.
    HIV Med. 2019 Jun 28. doi: 10.1111/hiv.12762.
    >> Share

  242. BORGHETTI A, Moschese D, Cingolani A, Baldin G, et al
    Lamivudine-based maintenance antiretroviral therapies in patients living with HIV-1 with suppressed HIV RNA: derivation of a predictive score for virological failure.
    HIV Med. 2019 Jun 25. doi: 10.1111/hiv.12759.
    >> Share

  243. BRISTOWE K, Clift P, James R, Josh J, et al
    Towards person-centred care for people living with HIV: what core outcomes matter, and how might we assess them? A cross-national multi-centre qualitative study with key stakeholders.
    HIV Med. 2019 Jun 4. doi: 10.1111/hiv.12758.
    >> Share

  244. SHAFRAN SD, Di Perri G, Esser S, Lelievre JD, et al
    Planning HIV therapy to prevent future comorbidities: patient years for tenofovir alafenamide.
    HIV Med. 2019;20 Suppl 7:1-16.
    >> Share

    May 2019
  245. KLOS B, Patel P, Rose C, Bush T, et al
    Lower serum adiponectin level is associated with lipodystrophy among HIV-infected men in the Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN) study.
    HIV Med. 2019 May 31. doi: 10.1111/hiv.12754.
    >> Share

  246. ELVSTAM O, Medstrand P, Jansson M, Isberg PE, et al
    Is low-level HIV-1 viraemia associated with elevated levels of markers of immune activation, coagulation and cardiovascular disease?
    HIV Med. 2019 May 30. doi: 10.1111/hiv.12756.
    >> Share

  247. FRANGE P, Avettand-Fenoel V, Veber F, Blanche S, et al
    Similar efficacy and safety of dolutegravir between age groups of HIV-1-infected paediatric and young adult patients aged 5 years and older.
    HIV Med. 2019 May 29. doi: 10.1111/hiv.12752.
    >> Share

  248. MENDEZ-LOPEZ A, McKee M, Stuckler D, Granich R, et al
    Population uptake and effectiveness of test-and-treat antiretroviral therapy guidelines for preventing the global spread of HIV: an ecological cross-national analysis.
    HIV Med. 2019 May 29. doi: 10.1111/hiv.12750.
    >> Share

  249. SPINNER CD, Lang GF, Boesecke C, Jessen H, et al
    Summary of German-Austrian HIV PrEP guideline.
    HIV Med. 2019 May 29. doi: 10.1111/hiv.12724.
    >> Share

  250. KRAMER JR, Hartman C, White DL, Royse K, et al
    Validation of HIV-infected cohort identification using automated clinical data in the Department of Veterans Affairs.
    HIV Med. 2019 May 26. doi: 10.1111/hiv.12757.
    >> Share

  251. D'SOUZA RR, Gopalan BP, Rajnala N, Phetsouphanh C, et al
    Increased monocyte activation with age among HIV-infected long term non-progressor children: implications for early treatment initiation.
    HIV Med. 2019 May 26. doi: 10.1111/hiv.12751.
    >> Share

  252. VALLEJO A, Molano M, Monsalvo-Hernando M, Hernandez-Walias F, et al
    Switching to dual antiretroviral regimens is associated with improvement or no changes in activation and inflammation markers in virologically suppressed HIV-1-infected patients: the TRILOBITHE pilot study.
    HIV Med. 2019 May 26. doi: 10.1111/hiv.12749.
    >> Share

  253. WAYAL S, Reid D, Weatherburn P, Blomquist P, et al
    Association between knowledge, risk behaviours, and testing for sexually transmitted infections among men who have sex with men: findings from a large online survey in the United Kingdom.
    HIV Med. 2019 May 24. doi: 10.1111/hiv.12753.
    >> Share


  254. CD4 recovery following antiretroviral treatment interruptions in children and adolescents with HIV infection in Europe and Thailand.
    HIV Med. 2019 May 16. doi: 10.1111/hiv.12745.
    >> Share

  255. HACHFELD A, Darling K, Calmy A, Ledergerber B, et al
    Why do sub-Saharan Africans present late for HIV care in Switzerland?
    HIV Med. 2019 May 6. doi: 10.1111/hiv.12727.
    >> Share


  256. British HIV Association guidelines for the management of tuberculosis in adults living with HIV 2019.
    HIV Med. 2019;20 Suppl 6:s2-s83.
    >> Share

    April 2019
  257. ONG KJ, van Hoek AJ, Harris RJ, Figueroa J, et al
    HIV care cost in England: a cross-sectional analysis of antiretroviral treatment and the impact of generic introduction.
    HIV Med. 2019 Apr 29. doi: 10.1111/hiv.12725.
    >> Share

  258. BLOKHINA E, Krupitsky EM, Cheng DM, Walley AY, et al
    Evolution of illicit opioid use among people with HIV infection in St Petersburg, Russia, in the period 2004-2015.
    HIV Med. 2019 Apr 29. doi: 10.1111/hiv.12741.
    >> Share

  259. BUCK WC, Puliyanda D, Nielsen-Saines K
    Letter to Editor: HIV medicine.
    HIV Med. 2019 Apr 29. doi: 10.1111/hiv.12743.
    >> Share

  260. MARTIN-IGUACEL R, Pedersen C, Omland LH, Sondergaard J, et al
    Primary health care: an opportunity for early identification of people living with undiagnosed HIV infection.
    HIV Med. 2019 Apr 24. doi: 10.1111/hiv.12735.
    >> Share

  261. RIVERO-JUAREZ A, Tellez F, Castano-Carracedo M, Merino D, et al
    Parenteral drug use as the main barrier to hepatitis C treatment uptake in HIV-infected patients.
    HIV Med. 2019 Apr 22. doi: 10.1111/hiv.12715.
    >> Share

  262. SILVA BF, Peixoto G, da Luz SR, de Moraes S, et al
    Adverse effects of chronic treatment with the Main subclasses of highly active antiretroviral therapy: a systematic review.
    HIV Med. 2019 Apr 22. doi: 10.1111/hiv.12733.
    >> Share

  263. PARRY S, Curtis H, Chadwick D
    Psychological wellbeing and use of alcohol and recreational drugs: results of the British HIV Association (BHIVA) national audit 2017.
    HIV Med. 2019 Apr 22. doi: 10.1111/hiv.12744.
    >> Share

  264. GUO C, Yu M, Deng X, Gong H, et al
    The characteristics of internet-based venue sex-seeking and mobility among money boys in Tianjin, China.
    HIV Med. 2019 Apr 22. doi: 10.1111/hiv.12746.
    >> Share

  265. JIAMSAKUL A, Kiertiburanakul S, Ng OT, Chaiwarith R, et al
    Long-term loss to follow-up in the TREAT Asia HIV Observational Database (TAHOD).
    HIV Med. 2019 Apr 12. doi: 10.1111/hiv.12734.
    >> Share

  266. BOCK P, Nel K, Fatti G, Sloot R, et al
    Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (Po
    HIV Med. 2019 Apr 8. doi: 10.1111/hiv.12729.
    >> Share

  267. MORENO S, Perno CF, Mallon PW, Behrens G, et al
    Two-drug vs. three-drug combinations for HIV-1: Do we have enough data to make the switch?
    HIV Med. 2019;20 Suppl 4:2-12.
    >> Share


  268. Abstracts of the 25th Annual Conference of the British HIV Association (BHIVA), Bournemouth, UK, 2-5 April 2019.
    HIV Med. 2019;20 Suppl 5:3-75.
    >> Share

    March 2019
  269. ASSOUMOU L, Thormann F, Soulie C, Caby F, et al
    Routine screening for HIV, hepatitis B virus and hepatitis C virus in individuals undergoing oral and maxillofacial surgery.
    HIV Med. 2019 Mar 29. doi: 10.1111/hiv.12732.
    >> Share

  270. TADESSE BT, Foster A, Aklillu E
    Rebuttal: Response to the comments by Buck et al. on our published article: Hepatic and renal toxicity and associated factors among HIV-infected children on antiretroviral therapy: a prospective cohort study; HIV Medicine (2019), 20, 147-156.
    HIV Med. 2019 Mar 29. doi: 10.1111/hiv.12742.
    >> Share

  271. PEREZ-PATRIGEON S, Camiro-Zuniga A, Jaramillo-Jante MR, Belaunzaran-Zamudio PF, et al
    Immediate treatment of acute HIV in a tertiary healthcare center: bridging gaps in communication using smartphones.
    HIV Med. 2019 Mar 29. doi: 10.1111/hiv.12713.
    >> Share

  272. PERRAM J, O'Dwyer E, Holloway C
    Use of dabigatran with antiretrovirals.
    HIV Med. 2019 Mar 29. doi: 10.1111/hiv.12722.
    >> Share

  273. SO-ARMAH K, Gupta SK, Kundu S, Stewart JC, et al
    Depression and all-cause mortality risk in HIV-infected and HIV-uninfected US veterans: a cohort study.
    HIV Med. 2019 Mar 29. doi: 10.1111/hiv.12726.
    >> Share

  274. DI BIAGIO A, Taramasso L, Gustinetti G, Burastero G, et al
    Missed opportunities to prevent mother-to-child transmission of HIV in Italy.
    HIV Med. 2019 Mar 29. doi: 10.1111/hiv.12728.
    >> Share

  275. WILLIAMS D, Reicher I, Mohammed H, Richardson D, et al
    Secondary adrenal insufficiency from steroid use and co-prescribing of cytochrome p450 3A4 inhibitors.
    HIV Med. 2019 Mar 29. doi: 10.1111/hiv.12723.
    >> Share

  276. DHILLON S, Sabin CA, Alagaratnam J, Bagkeris E, et al
    Level of agreement between frequently used cardiovascular risk calculators in people living with HIV.
    HIV Med. 2019 Mar 14. doi: 10.1111/hiv.12731.
    >> Share

  277. CRAUWELS HM, Osiyemi O, Zorrilla C, Bicer C, et al
    Reduced exposure to darunavir and cobicistat in HIV-1-infected pregnant women receiving a darunavir/cobicistat-based regimen.
    HIV Med. 2019 Mar 14. doi: 10.1111/hiv.12721.
    >> Share

  278. FITZPATRICK C, Lowe M, Richardson D
    Sexually transmitted infection testing and rates in men who have sex with men (MSM) using HIV pre-exposure prophylaxis.
    HIV Med. 2019 Mar 14. doi: 10.1111/hiv.12736.
    >> Share


  279. Severe haematologic toxicity is rare in high risk HIV-exposed infants receiving combination neonatal prophylaxis.
    HIV Med. 2019 Mar 7. doi: 10.1111/hiv.12696.
    >> Share

  280. BOYD MA, Boffito M, Castagna A, Estrada V, et al
    Rapid initiation of antiretroviral therapy at HIV diagnosis: definition, process, knowledge gaps.
    HIV Med. 2019;20 Suppl 1:3-11.
    >> Share


  281. British HIV Association guidelines for the management of HIV in pregnancy and postpartum 2018.
    HIV Med. 2019;20 Suppl 3:s2-s85.
    >> Share


  282. BHIVA/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP) 2018.
    HIV Med. 2019;20 Suppl 2:s2-s80.
    >> Share

    February 2019
  283. AMELE S, Peters L, Sluzhynska M, Yakovlev A, et al
    Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA.
    HIV Med. 2019 Feb 8. doi: 10.1111/hiv.12711.
    >> Share

  284. DE FRANCESCO D, Underwood J, Bagkeris E, Boffito M, et al
    Depression, lifestyle factors and cognitive function in people living with HIV and comparable HIV-negative controls.
    HIV Med. 2019 Feb 8. doi: 10.1111/hiv.12714.
    >> Share

    January 2019
  285. JACQUET JM, Donnadieu-Rigole H, Peries M, Makinson A, et al
    Implementing screening, brief intervention and referral to treatment in a French cohort of people living with HIV: a pilot study.
    HIV Med. 2019 Jan 31. doi: 10.1111/hiv.12709.
    >> Share

  286. JOHNSON SM, Standing JF, Klein N, Irwin AD, et al
    A case for reduced frequency of CD4 count monitoring for children on combination antiretroviral therapy with consistently undetectable HIV viral load.
    HIV Med. 2019 Jan 28. doi: 10.1111/hiv.12706.
    >> Share

  287. GRABAR S, Hleyhel M, Belot A, Bouvier AM, et al
    Invasive cervical cancer in HIV-infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)-Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS)
    HIV Med. 2019 Jan 28. doi: 10.1111/hiv.12703.
    >> Share

  288. IRELAND G, Simmons R, Balogun K, Kirwan P, et al
    HIV coinfection among persons diagnosed with hepatitis B in England in 2008-2014.
    HIV Med. 2019 Jan 28. doi: 10.1111/hiv.12707.
    >> Share

  289. MATIGNON M, Lelievre JD, Lahiani A, Abbassi K, et al
    Low incidence of acute rejection within 6 months of kidney transplantation in HIV-infected recipients treated with raltegravir: the Agence Nationale de Recherche sur le Sida et les Hepatites Virales (ANRS) 153 TREVE trial.
    HIV Med. 2019 Jan 27. doi: 10.1111/hiv.12700.
    >> Share

  290. LLIBRE JM, Montoliu A, Miro JM, Domingo P, et al
    Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort.
    HIV Med. 2019 Jan 27. doi: 10.1111/hiv.12710.
    >> Share

  291. MALIN JJ, Boesecke C, Schwarze-Zander C, Wasmuth JC, et al
    Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfection.
    HIV Med. 2019 Jan 27. doi: 10.1111/hiv.12705.
    >> Share

  292. COLOMBA C, Saporito L, Gioe C, Tramuto F, et al
    Fatal measles as AIDS presentation in Italy.
    HIV Med. 2019 Jan 22. doi: 10.1111/hiv.12704.
    >> Share

  293. KRENTZ HB, Campbell S, Lahl M, Gill MJ, et al
    De-simplifying single-tablet antiretroviral treatments: uptake, risks and cost savings.
    HIV Med. 2019 Jan 11. doi: 10.1111/hiv.12701.
    >> Share

  294. DAKSHINA S, Olaru ID, Khan P, Raman L, et al
    Evaluation of weight-based prescription of antiretroviral therapy in children.
    HIV Med. 2019 Jan 11. doi: 10.1111/hiv.12702.
    >> Share

  295. COSTINIUK CT, Nitulescu R, Saneei Z, Wasef N, et al
    Prevalence and predictors of airflow obstruction in an HIV tertiary care clinic in Montreal, Canada: a cross-sectional study.
    HIV Med. 2019 Jan 8. doi: 10.1111/hiv.12699.
    >> Share

  296. BIJKER R, Jiamsakul A, Uy E, Kumarasamy N, et al
    Cardiovascular disease-related mortality and factors associated with cardiovascular events in the TREAT Asia HIV Observational Database (TAHOD).
    HIV Med. 2019 Jan 8. doi: 10.1111/hiv.12687.
    >> Share


  297. Corrigendum.
    HIV Med. 2019;20:74-76.
    >> Share

    December 2018
  298. GRIFFITH DC, Farmer C, Gebo KA, Berry SA, et al
    Uptake and virological outcomes of single- versus multi-tablet antiretroviral regimens among treatment-naive youth in the HIV Research Network.
    HIV Med. 2018 Dec 18. doi: 10.1111/hiv.12695.
    >> Share

  299. POOL E, Winston A, Bagkeris E, Vera JH, et al
    High-risk behaviours, and their associations with mental health, adherence to antiretroviral therapy and HIV parameters, in HIV-positive men who have sex with men.
    HIV Med. 2018 Dec 12. doi: 10.1111/hiv.12690.
    >> Share

  300. GATEY C, Brun A, Hamet G, Diamantis S, et al
    Does region of origin influence the timing and outcome of first-line antiretroviral therapy in France?
    HIV Med. 2018 Dec 3. doi: 10.1111/hiv.12697.
    >> Share

    November 2018
  301. PUHR R, Petoumenos K, Huang R, Templeton DJ, et al
    Cardiovascular disease and diabetes in HIV-positive and HIV-negative gay and bisexual men over the age of 55 years in Australia: insights from the Australian Positive & Peers Longevity Evaluation Study.
    HIV Med. 2018 Nov 26. doi: 10.1111/hiv.12689.
    >> Share

  302. KENDALL CE, Raboud J, Donelle J, Loutfy M, et al
    Lost but not forgotten: A population-based study of mortality and care trajectories among people living with HIV who are lost to follow-up in Ontario, Canada.
    HIV Med. 2018 Nov 26. doi: 10.1111/hiv.12682.
    >> Share

  303. TADESSE BT, Foster BA, Kabeta A, Ayalew F, et al
    Hepatic and renal toxicity and associated factors among HIV-infected children on antiretroviral therapy: a prospective cohort study.
    HIV Med. 2018 Nov 26. doi: 10.1111/hiv.12693.
    >> Share

  304. D'ARMINIO MONFORTE A, Diaz-Cuervo H, De Luca A, Maggiolo F, et al
    Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naive for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014.
    HIV Med. 2018 Nov 21. doi: 10.1111/hiv.12683.
    >> Share

  305. MODICA S, Rossetti B, Lombardi F, Lagi F, et al
    Prevalence and determinants of resistance mutations in HIV-1-infected patients exposed to integrase inhibitors in a large Italian cohort.
    HIV Med. 2018 Nov 21. doi: 10.1111/hiv.12692.
    >> Share

  306. O'DONNELL K, Fitzgerald M, Quinlan M, Hickson F, et al
    Inequalities in HIV testing uptake and needs among men who have sex with men living in Ireland: findings from an internet survey.
    HIV Med. 2018 Nov 20. doi: 10.1111/hiv.12694.
    >> Share

  307. BALDIN G, Ciccullo A, Capetti A, Rusconi S, et al
    Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV-infected patients in clinical practice: results from a multicentre, ob
    HIV Med. 2018 Nov 20. doi: 10.1111/hiv.12688.
    >> Share

  308. WILTON J, Light L, Gardner S, Rachlis B, et al
    Late diagnosis, delayed presentation and late presentation among persons enrolled in a clinical HIV cohort in Ontario, Canada (1999-2013).
    HIV Med. 2018 Nov 14. doi: 10.1111/hiv.12686.
    >> Share

  309. GAMEIRO J, Agapito Fonseca J, Jorge S, Lopes JA, et al
    Acute kidney injury in HIV-infected patients: a critical review.
    HIV Med. 2018 Nov 8. doi: 10.1111/hiv.12685.
    >> Share

  310. ROTMAN L, Luo X, Thompson A, Mackesy-Amiti ME, et al
    Risk of neurosyphilis in HIV-infected persons with syphilis lacking signs or symptoms of central nervous system infection.
    HIV Med. 2018 Nov 7. doi: 10.1111/hiv.12677.
    >> Share


  311. A note of thanks to referees for Volume 19, 2018.
    HIV Med. 2018;19:756-758.
    >> Share

    October 2018
  312. BALASKO A, Keynan Y
    Shedding light on IRIS: from Pathophysiology to Treatment of Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome in HIV-Infected Individuals.
    HIV Med. 2018 Oct 25. doi: 10.1111/hiv.12676.
    >> Share

  313. LIEGEOIS F, Eymard-Duvernay S, Boyer S, Maradan G, et al
    Heterogeneity of virological suppression in the national antiretroviral programme of Cameroon (ANRS 12288 EVOLCAM).
    HIV Med. 2018 Oct 25. doi: 10.1111/hiv.12681.
    >> Share

  314. KIROS YK, Elinav H, Gebreyesus A, Gebremeskel H, et al
    Identification and characterization of HIV positive Ethiopian elite controllers in both Africa and Israel.
    HIV Med. 2018 Oct 14. doi: 10.1111/hiv.12680.
    >> Share

  315. WILLIAMS D, Scott J, Richardson D, Kingdon E, et al
    Management of Renal Disease: utility of a joint HIV-renal clinic.
    HIV Med. 2018 Oct 14. doi: 10.1111/hiv.12684.
    >> Share

  316. CHEN J, Zhang R, Shen Y, Liu L, et al
    Serum cryptococcal antigen titre as a diagnostic tool and a predictor of mortality in HIV-infected patients with cryptococcal meningitis.
    HIV Med. 2018 Oct 12. doi: 10.1111/hiv.12679.
    >> Share

    September 2018
  317. WIJTING I, Rutsaert SL, Rokx C, Burger DM, et al
    Predictors of virological failure in HIV-1-infected patients switching to dolutegravir maintenance monotherapy.
    HIV Med. 2018 Sep 30. doi: 10.1111/hiv.12675.
    >> Share

  318. ASTON SJ, Doherty K, Black B, Davies G, et al
    Latent tuberculosis infection screening in HIV-infected patients: guidelines versus everyday practice in a UK HIV centre.
    HIV Med. 2018 Sep 30. doi: 10.1111/hiv.12678.
    >> Share

  319. BALDE A, Lievre L, Maiga AI, Diallo F, et al
    Risk factors for loss to follow-up, transfer or death among people living with HIV on their first antiretroviral therapy regimen in Mali.
    HIV Med. 2018 Sep 30. doi: 10.1111/hiv.12668.
    >> Share

  320. KNUDSEN A, Kristoffersen US, Panum I, Hansen YB, et al
    Coronary artery calcium and intima-media thickness are associated with level of cytomegalovirus immunoglobulin G in HIV-infected patients.
    HIV Med. 2018 Sep 4. doi: 10.1111/hiv.12672.
    >> Share

  321. MARCUS JL, Hurley LB, Prasad A, Zaroff J, et al
    Recurrence after hospitalization for acute coronary syndrome among HIV-infected and HIV-uninfected individuals.
    HIV Med. 2018 Sep 4. doi: 10.1111/hiv.12670.
    >> Share

    August 2018
  322. JASPAL R, Lopes B, Bayley J, Papaloukas P, et al
    A structural equation model to predict pre-exposure prophylaxis acceptability in men who have sex with men in Leicester, UK.
    HIV Med. 2018 Aug 30. doi: 10.1111/hiv.12667.
    >> Share

  323. AURPIBUL L, Sugandhavesa P, Srithanaviboonchai K, Sitthi W, et al
    Peripheral artery disease in HIV-infected older adults on antiretroviral treatment in Thailand.
    HIV Med. 2018 Aug 30. doi: 10.1111/hiv.12671.
    >> Share

  324. THUDIUM RF, Lundgren J, Benfield T, Nordestgaard BG, et al
    HIV infection is independently associated with a higher concentration of alpha-1 antitrypsin.
    HIV Med. 2018 Aug 30. doi: 10.1111/hiv.12666.
    >> Share

  325. KIEFER EM, Hoover DR, Shi Q, Dusingize JC, et al
    Longitudinal evaluation of markers of inflammation in HIV-positive and HIV-negative Rwandan women.
    HIV Med. 2018 Aug 30. doi: 10.1111/hiv.12665.
    >> Share

  326. RONIT A, Benfield T, Mocroft A, Gerstoft J, et al
    Diagnostic performance of clinical characteristics to detect airflow limitation in people living with HIV and in uninfected controls.
    HIV Med. 2018 Aug 30. doi: 10.1111/hiv.12669.
    >> Share

  327. DEWAR C, Anstee QM, Price DA, Payne B, et al
    Central obesity and nonalcoholic fatty liver disease in people living with HIV: a case for targeted screening?
    HIV Med. 2018 Aug 30. doi: 10.1111/hiv.12674.
    >> Share

  328. FENTON K, Cropp A, Chauhan M, Foster K, et al
    Earlier diagnosis of HIV infection through visual HIV testing prompts.
    HIV Med. 2018 Aug 30. doi: 10.1111/hiv.12673.
    >> Share

  329. HAGINS D, Orkin C, Daar ES, Mills A, et al
    Switching to coformulated rilpivirine (RPV), emtricitabine (FTC) and tenofovir alafenamide from either RPV, FTC and tenofovir disoproxil fumarate (TDF) or efavirenz, FTC and TDF: 96-week results from two randomized clinical trials.
    HIV Med. 2018 Aug 12. doi: 10.1111/hiv.12664.
    >> Share

  330. LAM JO, Barnell GM, Merchant M, Ellis CG, et al
    Acceptability of high-resolution anoscopy for anal cancer screening in HIV-infected patients.
    HIV Med. 2018 Aug 6. doi: 10.1111/hiv.12663.
    >> Share

  331. SEERS T, Vassallo P, Pollock K, Thornhill JP, et al
    CD4:CD8 ratio in children with perinatally acquired HIV-1 infection.
    HIV Med. 2018 Aug 6. doi: 10.1111/hiv.12642.
    >> Share


  332. Welcome Letter.
    HIV Med. 2018;19 Suppl 3:3.
    >> Share

  333. SMITH DE, Woolley IJ, Russell DB, Bisshop F, et al
    HIV in practice: current approaches and challenges in the diagnosis, treatment and management of HIV infection in Australia.
    HIV Med. 2018;19 Suppl 3:5-23.
    >> Share

    July 2018
  334. NASSEREDDINE H, Charpentier C, Bucau M, Joly V, et al
    Interest of cytology combined with Xpert((R)) HPV and Anyplex((R)) II HPV28 Detection human papillomavirus (HPV) typing: differential profiles of anal and cervical HPV lesions in HIV-infected patients on antiretroviral therapy.
    HIV Med. 2018 Jul 30. doi: 10.1111/hiv.12661.
    >> Share

  335. KUSEJKO K, Marzel A, Hampel B, Bachmann N, et al
    Quantifying the drivers of HIV transmission and prevention in men who have sex with men: a population model-based analysis in Switzerland.
    HIV Med. 2018 Jul 26. doi: 10.1111/hiv.12660.
    >> Share

  336. IRELAND G, Delpech V, Kirwan P, Croxford S, et al
    Prevalence of diagnosed HIV infection among persons with hepatitis C virus infection: England, 2008-2014.
    HIV Med. 2018 Jul 26. doi: 10.1111/hiv.12662.
    >> Share

  337. HATLEBERG CI, Ryom L, d'Arminio Monforte A, Fontas E, et al
    Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
    HIV Med. 2018 Jul 18. doi: 10.1111/hiv.12639.
    >> Share

  338. ACOSTA MC, Kundro M, Viloria G, Peresin A, et al
    The role of brain biopsy in the clinical management of HIV-related focal brain lesions.
    HIV Med. 2018 Jul 13. doi: 10.1111/hiv.12646.
    >> Share

  339. GALLIEN S, Massetti M, Flandre P, Leleu H, et al
    Comparison of 48-week efficacies of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide and nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimens: a systematic review and network meta-analysis.
    HIV Med. 2018 Jul 13. doi: 10.1111/hiv.12643.
    >> Share

  340. SCHOLTEN M, Suarez I, Platten M, Kummerle T, et al
    To prescribe, or not to prescribe: decision making in HIV-1 post-exposure prophylaxis.
    HIV Med. 2018 Jul 11. doi: 10.1111/hiv.12645.
    >> Share

  341. KOWALSKA JD, Bursa D, Gokengin D, Jilich D, et al
    HIV health care providers are ready to introduce pre-exposure prophylaxis in Central and Eastern Europe and neighbouring countries: data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group.
    HIV Med. 2018 Jul 10. doi: 10.1111/hiv.12641.
    >> Share

  342. HABERLEN SA, Jacobson LP, Palella FJ Jr, Dobs A, et al
    To T or not to T: Differences in Testosterone Use and Discontinuation by HIV Serostatus among Men who Have Sex with Men.
    HIV Med. 2018 Jul 10. doi: 10.1111/hiv.12644.
    >> Share

  343. AHLSTROM MG, Knudsen A, Ullum H, Gerstoft J, et al
    Association between smoking status assessed with plasma-cotinine and inflammatory and endothelial biomarkers in HIV-positive and HIV-negative individuals.
    HIV Med. 2018 Jul 9. doi: 10.1111/hiv.12647.
    >> Share

  344. KRZNARIC I, Bickel M, Carganico A, De Leuw P, et al
    Similar long-term efficacy of dual therapy containing raltegravir and a boosted protease inhibitor versus standard triple therapies in pretreated HIV-1-infected patients in a retrospective, real-life cohort of 14 years.
    HIV Med. 2018 Jul 3. doi: 10.1111/hiv.12636.
    >> Share

  345. HONGLER J, Musaazi J, Ledergerber B, Eberhard N, et al
    Comparison of Lowenstein-Jensen and BACTEC MGIT 960 culture for Mycobacterium tuberculosis in people living with HIV.
    HIV Med. 2018 Jul 3. doi: 10.1111/hiv.12635.
    >> Share

  346. BROWN LJ, Tan KS, Guerra LE, Naidoo CJ, et al
    Using behavioural insights to increase HIV self-sampling kit returns: a randomized controlled text message trial to improve England's HIV self-sampling service.
    HIV Med. 2018 Jul 2. doi: 10.1111/hiv.12634.
    >> Share

    June 2018
  347. FABBRI G, Mastrorosa I, Vergori A, Timelli L, et al
    Liver stiffness reduction and serum fibrosis score improvement in HIV/hepatitis C virus-coinfected patients treated with direct-acting antivirals.
    HIV Med. 2018 Jun 28. doi: 10.1111/hiv.12632.
    >> Share

  348. ROSSETTI B, Di Giambenedetto S, Torti C, Postorino MC, et al
    Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016.
    HIV Med. 2018 Jun 22. doi: 10.1111/hiv.12640.
    >> Share

  349. SCULIER D, Doco-Lecompte T, Yerly S, Metzner KJ, et al
    Stable HIV-1 reservoirs on dolutegravir maintenance monotherapy: the MONODO study.
    HIV Med. 2018 Jun 22. doi: 10.1111/hiv.12626.
    >> Share

  350. CASADO JL, Santiuste C, Vivancos MJ, Monsalvo M, et al
    Switching to abacavir versus use of a nucleoside-sparing dual regimen for HIV-infected patients with tenofovir-associated renal toxicity.
    HIV Med. 2018 Jun 22. doi: 10.1111/hiv.12630.
    >> Share

  351. SAGNELLI C, Uberti-Foppa C, Hasson H, Bellini G, et al
    In vivo evidence that the cannabinoid receptor 2-63 RR variant is associated with the acquisition and/or expansion of HIV infection.
    HIV Med. 2018 Jun 22. doi: 10.1111/hiv.12638.
    >> Share

  352. BROWN AE, Nash S, Connor N, Kirwan PD, et al
    Towards elimination of HIV transmission, AIDS and HIV-related deaths in the UK.
    HIV Med. 2018 Jun 20. doi: 10.1111/hiv.12617.
    >> Share

  353. MAO X, Wang Z, Hu Q, Huang C, et al
    HIV incidence is rapidly increasing with age among young men who have sex with men in China: a multicentre cross-sectional survey.
    HIV Med. 2018 Jun 19. doi: 10.1111/hiv.12623.
    >> Share

  354. CHU DT, Vo Truong Nhu N, Tao Y, Le Hoang S, et al
    Achievements and challenges in HIV/AIDS control in Vietnam.
    HIV Med. 2018 Jun 6. doi: 10.1111/hiv.12631.
    >> Share

  355. FOCA E, Cavaglia G, Rusconi S, Cascavilla A, et al
    Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study.
    HIV Med. 2018 Jun 4. doi: 10.1111/hiv.12624.
    >> Share

  356. HENTZIEN M, Cabie A, Pugliese P, Billaud E, et al
    Factors associated with deaths from suicide in a French nationwide HIV-infected cohort.
    HIV Med. 2018 Jun 1. doi: 10.1111/hiv.12633.
    >> Share

    May 2018
  357. TARAMASSO L, Di Biagio A, Maggiolo F, Tavelli A, et al
    First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison.
    HIV Med. 2018 May 30. doi: 10.1111/hiv.12628.
    >> Share

  358. PAKIANATHAN M, Whittaker W, Lee MJ, Avery J, et al
    Chemsex and new HIV diagnosis in gay, bisexual and other men who have sex with men attending sexual health clinics.
    HIV Med. 2018 May 22. doi: 10.1111/hiv.12629.
    >> Share

  359. GUO F, Cheng X, Hsieh E, Du X, et al
    Prospective plasma efavirenz concentration assessment in Chinese HIV-infected adults enrolled in a large multicentre study.
    HIV Med. 2018 May 15. doi: 10.1111/hiv.12607.
    >> Share

  360. TRUNFIO M, Vai D, Montrucchio C, Alcantarini C, et al
    Diagnostic accuracy of new and old cognitive screening tools for HIV-associated neurocognitive disorders.
    HIV Med. 2018 May 15. doi: 10.1111/hiv.12622.
    >> Share

  361. AHMED SI, Hasan SS, Babar MG
    Patients' involvement in the care process: time to value nontraditional indicators in HIV care.
    HIV Med. 2018 May 10. doi: 10.1111/hiv.12620.
    >> Share

  362. GONZALEZ-CORDON A, Domenech M, Camafort M, Martinez-Rebollar M, et al
    Subclinical cardiovascular disease in patients starting contemporary protease inhibitors.
    HIV Med. 2018 May 10. doi: 10.1111/hiv.12619.
    >> Share

  363. CROXFORD S, Yin Z, Kall M, Burns F, et al
    Where do we diagnose HIV infection? Monitoring new diagnoses made in nontraditional settings in England, Wales and Northern Ireland.
    HIV Med. 2018 May 9. doi: 10.1111/hiv.12627.
    >> Share

  364. JAKOBSEN SF, Raben D, Sperle I, Lazarus JV, et al
    Scale-up of HIV self-testing.
    HIV Med. 2018 May 8. doi: 10.1111/hiv.12618.
    >> Share

  365. BROWN AE, Attawell K, Hales D, Rice BD, et al
    Monitoring the HIV continuum of care in key populations across Europe and Central Asia.
    HIV Med. 2018 May 8. doi: 10.1111/hiv.12603.
    >> Share

    April 2018
  366. CRESSWELL FV, Ellis J, Hartley J, Sabin CA, et al
    A systematic review of risk of HIV transmission through biting or spitting: implications for policy.
    HIV Med. 2018 Apr 23. doi: 10.1111/hiv.12625.
    >> Share

  367. JIAMSAKUL A, Yunihastuti E, Van Nguyen K, Merati TP, et al
    Mortality following diagnosis of tuberculosis in HIV-infected patients in Asia.
    HIV Med. 2018 Apr 23. doi: 10.1111/hiv.12621.
    >> Share

  368. MASIA M, Padilla S, Garcia JA, Bernardino JI, et al
    Decreasing rates of acute myocardial infarction in people living with HIV: a nationwide cohort study in Spain, 2004-2015.
    HIV Med. 2018 Apr 23. doi: 10.1111/hiv.12616.
    >> Share

  369. GOMPELS M, Michael S, Jose S, Hill T, et al
    The use of funnel plots with regression as a tool to visually compare HIV treatment outcomes between centres adjusting for patient characteristics and size: a UK Collaborative HIV Cohort study.
    HIV Med. 2018 Apr 14. doi: 10.1111/hiv.12604.
    >> Share


  370. Abstracts of the 4th Joint Conference of the British HIV Association (BHIVA) with the British Association for Sexual Health and HIV (BASHH), Edinburgh, UK, 17-20 April 2018.
    HIV Med. 2018;19 Suppl 2:s5-s152.
    >> Share

    March 2018
  371. DAUBY N, Martin C, Hainaut M, Grammens T, et al
    Prevalence and risk factors of measles seronegativity in a cohort of HIV-positive subjects: a retrospective study.
    HIV Med. 2018 Mar 24. doi: 10.1111/hiv.12610.
    >> Share

  372. AEBI-POPP K, Wandeler G, Salazar-Vizcaya L, Metzner K, et al
    Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with men.
    HIV Med. 2018 Mar 24. doi: 10.1111/hiv.12602.
    >> Share

  373. BORGHETTI A, Baldin G, Lombardi F, Ciccullo A, et al
    Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV-1 replication.
    HIV Med. 2018 Mar 24. doi: 10.1111/hiv.12611.
    >> Share

  374. NIMKAR S, Valvi C, Kadam D, Rewari BB, et al
    Loss to follow-up and mortality among HIV-infected adolescents receiving antiretroviral therapy in Pune, India.
    HIV Med. 2018 Mar 24. doi: 10.1111/hiv.12605.
    >> Share

  375. SEZGIN E, Van Natta ML, Thorne JE, Puhan MA, et al
    Secular trends in opportunistic infections, cancers and mortality in patients with AIDS during the era of modern combination antiretroviral therapy.
    HIV Med. 2018 Mar 24. doi: 10.1111/hiv.12609.
    >> Share

  376. HONGE BL, Jespersen S, Medina C, Te DS, et al
    The challenge of discriminating between HIV-1, HIV-2 and HIV-1/2 dual infections.
    HIV Med. 2018 Mar 24. doi: 10.1111/hiv.12606.
    >> Share

  377. RYOM L, Boesecke C, Bracchi M, Ambrosioni J, et al
    Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0.
    HIV Med. 2018 Mar 1. doi: 10.1111/hiv.12600.
    >> Share

    February 2018
  378. OPREA C, Ianache I, Calistru PI, Nica M, et al
    Increasing incidence of HIV- associated tuberculosis in Romanian injecting drug users.
    HIV Med. 2018 Feb 21. doi: 10.1111/hiv.12576.
    >> Share

  379. HAYNES BI, Pitkanen M, Kulasegaram R, Casey SJ, et al
    HIV: ageing, cognition and neuroimaging at 4-year follow-up.
    HIV Med. 2018 Feb 14. doi: 10.1111/hiv.12598.
    >> Share

  380. SANTOS JR, Cozzi-Lepri A, Phillips A, De Wit S, et al
    Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in Europe.
    HIV Med. 2018 Feb 1. doi: 10.1111/hiv.12581.
    >> Share

  381. ASPINALL EJ, Hutchinson SJ, Goldberg DJ, Valerio H, et al
    Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality - results from two surveys (2016).
    HIV Med. 2018;19 Suppl 1:11-15.
    >> Share

  382. RABEN D, Hoekstra M, Sperle I, Amato Gauci AJ, et al
    The HepHIV 2017 Conference in Malta: joining forces for the earlier diagnosis of HIV and viral hepatitis.
    HIV Med. 2018;19 Suppl 1:5-10.
    >> Share

  383. MEULBROEK M, Pujol F, Perez F, Dalmau-Bueno A, et al
    BCN Checkpoint: same-day confirmation of reactive HIV rapid test with Point Of Care HIV-RNA accelerates linkage to care and reduces anxiety.
    HIV Med. 2018;19 Suppl 1:63-65.
    >> Share

  384. POWER L, Hows J, Jakobsen SF
    Key findings on legal and regulatory barriers to HIV testing and access to care across Europe.
    HIV Med. 2018;19 Suppl 1:58-62.
    >> Share

  385. ANAGNOSTOU O, Fotiou A, Kanavou E, Antaraki A, et al
    Factors associated with HCV test uptake in heroin users entering substitution treatment in Greece.
    HIV Med. 2018;19 Suppl 1:34-39.
    >> Share

  386. SCHWEITZER AM, Bogdan M, Corduneanu A, Ciocea I, et al
    Role of pretest counseling sessions on increasing subjective knowledge about HIV and hepatitis transmission among the beneficiaries of a free of charge, voluntary counseling and testing program in Constanta, Romania.
    HIV Med. 2018;19 Suppl 1:66-70.
    >> Share

  387. CROXFORD S, Burns F, Copas A, Pharris A, et al
    Factors associated with delayed linkage to care following HIV diagnosis in the WHO European Region.
    HIV Med. 2018;19 Suppl 1:40-46.
    >> Share

  388. FERNANDEZ-LOPEZ L, Reyes-Uruena J, Agusti C, Kustec T, et al
    The COBATEST network: monitoring and evaluation of HIV community-based practices in Europe, 2014-2016.
    HIV Med. 2018;19 Suppl 1:21-26.
    >> Share

  389. RUUTEL K, Lemsalu L, Latt S
    Monitoring HIV-indicator condition guided HIV testing in Estonia.
    HIV Med. 2018;19 Suppl 1:47-51.
    >> Share

  390. HOYOS J, Mate T, Indave BI, Agusti C, et al
    Knowledge, actual and potential use of HIV self-sampling testing kits among MSM recruited in eight European countries.
    HIV Med. 2018;19 Suppl 1:27-33.
    >> Share

  391. PLATTEAU T, van Lankveld J, Apers L, Fransen K, et al
    HIV testing for key populations in Europe: A decade of technological innovation and patient empowerment complement the role of health care professionals.
    HIV Med. 2018;19 Suppl 1:71-76.
    >> Share

  392. RUUTEL K, Kallavus K, Tomera I
    Monitoring anonymous HIV testing in Estonia from 2005 to 2015.
    HIV Med. 2018;19 Suppl 1:16-20.
    >> Share

  393. BRADSHAW D, Rae C, Rayment M, Turner N, et al
    HIV/HCV/HBV testing in the emergency department: a feasibility and seroprevalence study.
    HIV Med. 2018;19 Suppl 1:52-57.
    >> Share

    January 2018
  394. CICCULLO A, Gagliardini R, Baldin G, Borghetti A, et al
    An outbreak of acute hepatitis A among young adult men: clinical features and HIV coinfection rate from a large teaching hospital in Rome, Italy.
    HIV Med. 2018 Jan 29. doi: 10.1111/hiv.12597.
    >> Share

  395. BISCHOFF J, Mauss S, Cordes C, Lutz T, et al
    Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?
    HIV Med. 2018 Jan 25. doi: 10.1111/hiv.12579.
    >> Share

  396. KRENTZ HB, Campbell S, Gill VC, Gill MJ, et al
    Patient perspectives on de-simplifying their single-tablet co-formulated antiretroviral therapy for societal cost savings.
    HIV Med. 2018 Jan 25. doi: 10.1111/hiv.12578.
    >> Share

  397. DI CARLOFELICE M, Everitt A, Muir D, Winston A, et al
    Cerebrospinal fluid HIV RNA in persons living with HIV.
    HIV Med. 2018 Jan 25. doi: 10.1111/hiv.12594.
    >> Share

  398. LIU Z, Fang Q, Zuo J, Minhas V, et al
    The world-wide incidence of Kaposi's sarcoma in the HIV/AIDS era.
    HIV Med. 2018 Jan 25. doi: 10.1111/hiv.12584.
    >> Share

  399. PUFALL EL, Kall M, Shahmanesh M, Nardone A, et al
    Sexualized drug use ('chemsex') and high-risk sexual behaviours in HIV-positive men who have sex with men.
    HIV Med. 2018 Jan 24. doi: 10.1111/hiv.12574.
    >> Share

  400. KWAN N, Wong A, Fang Y, Wang Z, et al
    'Get an early check - Chrysanthemum tea': An outcome evaluation of a multimedia campaign promoting HIV testing among men who have sex with men in Hong Kong.
    HIV Med. 2018 Jan 24. doi: 10.1111/hiv.12583.
    >> Share

  401. KENT L, Amlani A, Vundavalli S, Ridha BH, et al
    Clinical use of brain magnetic resonance imaging for neurological symptoms in people living with HIV.
    HIV Med. 2018 Jan 19. doi: 10.1111/hiv.12580.
    >> Share

  402. AEBI-POPP K, Mercanti V, Voide C, Nemeth J, et al
    Neglect of attention to reproductive health in women with HIV infection: contraceptive use and unintended pregnancies in the Swiss HIV Cohort Study.
    HIV Med. 2018 Jan 16. doi: 10.1111/hiv.12582.
    >> Share

  403. PETERS H, Thorne C, Tookey PA, Byrne L, et al
    National audit of perinatal HIV infections in the UK, 2006-2013: what lessons can be learnt?
    HIV Med. 2018 Jan 16. doi: 10.1111/hiv.12577.
    >> Share

    December 2017
  404. LAHER A, Ariefdien N, Etlouba Y
    HIV prevalence among first-presentation psychotic patients.
    HIV Med. 2017 Dec 28. doi: 10.1111/hiv.12575.
    >> Share

  405. ROEN A, Laut K, Pelchen-Matthews A, Borodulina E, et al
    Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort.
    HIV Med. 2017 Dec 22. doi: 10.1111/hiv.12573.
    >> Share

  406. ROSENTHAL E, Fougerou-Leurent C, Renault A, Carrieri MP, et al
    Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study).
    HIV Med. 2017 Dec 7. doi: 10.1111/hiv.12571.
    >> Share

  407. MUKANYANGEZI MF, Sengpiel V, Manzi O, Tobin G, et al
    Screening for human papillomavirus, cervical cytological abnormalities and associated risk factors in HIV-positive and HIV-negative women in Rwanda.
    HIV Med. 2017 Dec 6. doi: 10.1111/hiv.12564.
    >> Share

  408. BASHIR T, Reddy K
    HbAHP-25 attenuates HIV-1 gp120 mediated inflammation and barrier dysfunction.
    HIV Med. 2017 Dec 6. doi: 10.1111/hiv.12569.
    >> Share

  409. SMOLDERS EJ, Smit C, de Kanter C, Dofferhoff A, et al
    Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfect.
    HIV Med. 2017 Dec 1. doi: 10.1111/hiv.12570.
    >> Share

  410. STIRRUP OT, Copas AJ, Phillips AN, Gill MJ, et al
    Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion.
    HIV Med. 2017 Dec 1. doi: 10.1111/hiv.12567.
    >> Share

    November 2017
  411. UTHAPPA CK, Allam RR, Pant R, Pal S, et al
    Pre-exposure prophylaxis: awareness, acceptability and risk compensation behaviour among men who have sex with men and the transgender population.
    HIV Med. 2017 Nov 27. doi: 10.1111/hiv.12572.
    >> Share

  412. ELGALIB A, Fidler S, Sabapathy K
    Hospital-based routine HIV testing in high-income countries: a systematic literature review.
    HIV Med. 2017 Nov 23. doi: 10.1111/hiv.12568.
    >> Share

  413. JAO J, Yu W, Patel K, Miller TL, et al
    Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study.
    HIV Med. 2017 Nov 21. doi: 10.1111/hiv.12566.
    >> Share

  414. KOWALSKA JD, Aebi-Popp K, Loutfy M, Post FA, et al
    Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group.
    HIV Med. 2017 Nov 21. doi: 10.1111/hiv.12565.
    >> Share

  415. YOUNG J, Smith C, Teira R, Reiss P, et al
    Antiretroviral pill count and clinical outcomes in treatment-naive patients with HIV infection.
    HIV Med. 2017 Nov 6. doi: 10.1111/hiv.12562.
    >> Share

  416. HUFF H, Merchant AT, Lonn E, Pullenayegum E, et al
    Vitamin D and progression of carotid intima-media thickness in HIV-positive Canadians.
    HIV Med. 2017 Nov 6. doi: 10.1111/hiv.12563.
    >> Share

  417. AIBIBULA W, Cox J, Hamelin AM, Moodie E, et al
    Food insecurity may lead to incomplete HIV viral suppression and less immune reconstitution among HIV/hepatitis C virus-coinfected people.
    HIV Med. 2017 Nov 2. doi: 10.1111/hiv.12561.
    >> Share


  418. A note of thanks to referees for Volume 18, 2017.
    HIV Med. 2017;18:793-795.
    >> Share

    October 2017
  419. DE WIT S, Battegay M, D'Arminio Monforte A, Lundgren JD, et al
    European AIDS Clinical Society Second Standard of Care Meeting, Brussels 16-17 November 2016: a summary.
    HIV Med. 2017 Oct 27. doi: 10.1111/hiv.12559.
    >> Share

  420. COZZI-LEPRI A, Zangerle R, Machala L, Zilmer K, et al
    Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens.
    HIV Med. 2017 Oct 6. doi: 10.1111/hiv.12557.
    >> Share

  421. FUREGATO M, Mitchell H, Ogaz D, Woodhall S, et al
    The role of frequent HIV testing in diagnosing HIV in men who have sex with men.
    HIV Med. 2017 Oct 6. doi: 10.1111/hiv.12558.
    >> Share

    March 2017
  422. TRON L, Lert F, Spire B, Dray-Spira R, et al
    Levels and determinants of breast and cervical cancer screening uptake in HIV-infected women compared with the general population in France.
    HIV Med. 2017;18:181-195.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016